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T cells are key cells in the coordination and implementation of the adaptive immune 
response. Specifically,  cytotoxic T  lymphocytes are responsible  for eliminating cells pre-
senting antigens on their surface either viral or tumor type. After antigen presentation, 
these cells must undergo a series of changes in the pattern of protein expression to rein-
force the signaling capability and allow movement to the site of action. In case of membrane 
proteins, there are changes in expression of surface receptors in order to receive chemical 
signals in the form of cytokines and other molecules, and also in adhesion molecules to 
allow the exit of the secondary lymphoid organs towards periphery. However, tumor cells 
can avoid CTL action in some cases, using escape mechanisms which limit their cytotoxic 
activity.
Signaling by diacylglycerol (DAG) plays an essential role in antigen presentation. Di-
acylglycerol kinase (DGK) enzymes family negatively regulates this response by phosphor-
ylation of DAG into phosphatidic acid (PA). ζ isoform (DGKζ) deficient mice CTL show in-
creased activation and better response to tumors. Furthermore, DGKζ deficiency has been 
associated with changes in protein expression on the cell surface related to cell adhesion. 
Determining the role of DGKζ deficiency in cell surface protein expression pattern can help 
to understand key aspects like its effects in tumor elimination.
In order to better understand the role of the DAG in CTL response, a proteomic study 
was designed to analyze the expression of proteins of these cells, with special interest in 
plasma membrane proteins. Firstly, a method of protein enrichment of the plasma mem-
brane by biotinylation was optimized in Jurkat T cells, while other strategies such as sub-
cellular fractionations were also tested to obtain better results. This method was then used 










Los linfocitos T son células fundamentales en la coordinación y ejecución de la res-
puesta inmune adaptativa. En concreto, los linfocitos T citotóxicos (CTL) se encargan de 
la eliminación de células infectadas por patógenos intracelulares o células tumorales que 
presentan en su superficie antígenos específicos. Tras la activación, los CTL experimentan 
una serie de cambios en el patrón de expresión de proteínas que les permiten aumentar su 
capacidad de señalización y su desplazamiento hacia los sitios de acción. En el caso de las 
proteínas de membrana presentan cambios en la expresión de receptores de citocinas y mo-
léculas de adhesión. Sin embargo, las células diana tumorales en algunos casos son capaces 
de eludir la acción de los CTL mediante mecanismos de evasión que limitan su capacidad 
efectora. 
La señalización del diacilglicerol (DAG) juega un papel esencial durante la activa-
ción de los linfocitos T. La familia de enzimas de las diacilglicerol quinasas (DGK) regula 







Para  comprender mejor  el  papel  de DGKζ  en  la  respuesta  de  las CTL,  diseñamos 
una aproximación proteómica para caracterizar las proteínas expresadas en su superficie 
celular. En primer lugar se optimizó en células T Jurkat un método de enriquecimiento de 
proteínas de la membrana plasmática mediante biotinilación, a la vez que se ensayaron 
otras estrategias como fraccionamientos subcelulares para obtener mejores rendimientos. 
Después se empleó este método con CTL, y se estudiaron los cambios en el patrón de ex-
presión de proteínas de membrana dependientes del DAG mediante la adición de un éster 
de forbol (PMA) o el análisis de CTL obtenidos a partir de ratones deficientes en DGKζ. 
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1. Inmune system and cancer 
1.1. Global vision of immune system
The immune system is in charge of protecting the host against pathogens and harm-
ful substances like toxins that invade the organism. It consists of specialized organs and 
tissues, as well as a series of effector cells and molecules that are responsible for carrying 




The cells of the innate immune system carry out the most immediate response as 
soon as pathogens cross the body’s natural barriers. These include macrophages, mast 
cells, dendritic cells and γδ T cells that are present in the tissues, or cells recruited from the 
bloodstream, such as monocytes, granulocytes and NK cells. These cells fight the infection 
and are also able to alert the components of adaptive immunity, which initiate a slower but 
specific response to pathogens.
The cells responsible for this adaptive immunity are T and B lymphocytes. The adap-





other cellular components by chemical signals known as cytokines. These include CD8 T 
lymphocytes or cytotoxic T lymphocytes (CTL), capable of killing infected cells which pres-
ent antigens on their surface (cellular response) (Murphy & Weaver, 2016).
1.2. Cytotoxic T lymphocytes
The cellular response through cellular cytotoxicity mechanisms is carried out by NK 




by ligands of the tumor necrosis factor (TNF) family and the release of cytolytic granules. In 
the first case, cell surface-expressed proteins such as Fas ligand (FasL), TNF or TNF-related 
apoptosis-inducing ligand (TRAIL) bind to their respective receptors in target cells: Fas, tu-
mor necrosis factor receptor (TNFR)-1, TRAIL receptor (TRAIL-R)-1 and TRAIL-R2. These 
receptors contain cytosolic death domains (DD) that bind to adapter proteins through the 
Fas associated death domain (FADD), triggering the activation of caspases 8 and 10 in-
volved in programmed cell death (Krammer et al., 2007). This mechanism is responsible 
for the death of activated cells in a process known as activation-induced cell death (AICD), 
one of the mechanisms that regulate the immune response. Patients with mutations in the 
Fas or FasL genes have a lymphoproliferative syndrome with T and B cells accumulation 
and autoimmune symptoms (Rieux-Laucat et al., 1995).
In the second mechanism, CTL release, in a polarized manner, lytic granules with 
cytolytic proteins that penetrate the target cell and cause its programmed cell death. In the 
case of CTL, the process begins with the recognition of the target cell by the CTL. The nu-
cleated cells of the organism express in the plasma membrane the major histocompatibility 
complex (MHC)-I molecules attached to fragments of proteins generated in the cell. CTL 
express in their surface the multimeric T cell receptor (TCR) capable of binding to these 
complexes. There are a large number of T cell clones with a different TCR generated from 
somatic recombination of the genes encoding the chains of this receptor. During an educa-
tion process in the thymus, T cell clones with TCRs capable of binding only to MHC-I:non-
self peptides complexes are selected. Thus, when a cell presents foreign peptides from viral 
or tumor origin, CTL circulating in the body will be able to recognize them and trigger a 
cytotoxic response (Germain, 1994).
This recognition establishes a signaling structure called the immunological synapse 
(Lee et al., 2002), in which the CTL and the target cell come into contact, align and reor-
ganize the molecules related to antigen recognition. This is known as supramolecular acti-
vation cluster (SMAC). After the antigenic recognition, a central region (cSMAC) is formed 
enriched with the molecules most involved in signaling such as TCR, CD8, CD28 and other 
co-receptors, and a peripheral region (pSMAC) that contains integrins and talin that pro-
motes adhesion between the two cells. Finally, there is a distal region (dSMAC) where the 
CD45 phosphatase is accumulated (Monks et al., 1998). At the same time, there is a polar-
ization towards the contact zone of the entire secretory machinery, which includes the Gol-
gi apparatus and the microtubule organizing center (MTOC). The reorientation of the CTL 
microtubule network towards the synapse facilitates the migration and exocytosis of lytic 
granules to the target cell through the cSMAC (Stinchcombe et al., 2006), in what is known 




the formation of the immunological synapse to the secretion of granules responsible for the 
death of the target cell in a few minutes, and after the CTL cell can repeat the process with 
another target cell (Bossi et al., 2002; Huppa & Davis, 2003) (Figure 1).
1.2.1.  Lytic granules
The release of lytic granules is the main mechanism of action of CTL cells. These 
granules are modified lysosomes, known as secretory lysosomes, which contain lysosomal 
enzymes hydrolases. In CTL, NK cells, mast cells and eosinophils, these granules also dis-
play lysosomal functions, at different of non-hematopoietic cells such as melanocytes and 
endothelial cells that contain both specialized granules and lysosomes that share biogene-
sis. In a CTL the number of lytic granules is approximately between 15-25, with a thickness 
of 700nm that in mouse can reach more than 5μm, and with one or more of electron-dense 
content core (Peters et al., 1991). This electron-dense core is formed by the proteins that 











Secretory domain: lytic granules
cSMAC: TCR, CD3, CD8, CD28, PKCθ
A)
B)
Figure 1: Immune synapse
A) Scheme showing the different phases of the cytolytic action carried out by 
the CTL. After recognizing the specific peptides presented by the MHC-I of the 
target cell, the CTL begins to reorient its cytolytic machinery, and the release 
of lytic granules will initiate apoptosis. B) Diagram of the immune synapse, 




proteins that arrive from the Golgi or other vesicles, so that these structures become more 
evident. This process takes several days since the activation of the CTL, and requires the 
gene expression and synthesis of the protein components (de Saint Basile et al., 2010).
Cytotoxic proteins are stored inside lytic granules under conditions such as acid pH 
or interaction with other proteins that prevent them from exerting their action. One of the 
main components of lytic granules is perforin, a protein with homology with members of 
the complement (Tschopp et al., 1986), which has the ability to form pores in the plasma 
membrane. Mice lacking perforin have impaired cytotoxic capacity in their CTL (Kägi et al., 
1994). At first it was thought that the mechanism of perforin action was to open pores in 
the target cell membrane causing its death. More recent studies have shown that perforin 
function facilitates the passage of a family of serin esterases, called granzymes, capable of 
activating caspase proteins in the target cell, which then initiate the apoptotic process. The 
presence of granzymes alone is not sufficient for the cytolytic action of CTL (L. Shi et al., 
1992), and they require the presence of perforin (Nakajima et al., 1995). Granzymes and 
perforin are found in the lytic granules forming complexes with the proteoglycan serglycin, 
which would act as scaffold. The entry of calcium into the CTL allows the exocytosis of the 
granules and the release of these complexes to the synaptic cleft. The mechanism by which 
perforin allows granzymes to enter into the target cell is controversial. It is thought that per-
forin, through the formation of pores or even incomplete pore structures, could temporarily 
permeabilize the membrane and allow the passage of granzymes (Lopez et al., 2013). Some 
studies suggest that granzymes would be endocytosed through the mannose-6-phosphate 
receptor (Motyka et al., 2000), and perforin would facilitate their exit from the endosome 
towards the cytosol, allowing its cytolytic action. However the content of the endosomes 
would lack the calcium concentration and the pH conditions necessary for the perforin to 
form pores (Gerasimenko et al., 1998).
Until now 5 isoforms of granzyme in human (A, B, H, K and M) and 10 in mouse 
(A-G, K, M and N) have been described (Bovenschen & Kummer, 2010). The most stud-
ied isoform in the induction of cell death is granzyme B. This protein has several targets, 
including BH3 interacting-domain death agonist (BID), whose proteolytic cleavage alters 
the permeability of the mitochondria and causes the release of cytochrome c to the cytosol, 
with a proapoptotic effect (Sutton et al., 2000). Another way of action of granzyme B  is 
the cleavage and activation of pro-caspase 3 that, in its active form, degrades inhibitor of 
caspase-activated DNase (ICAD), a DNA inhibitor responsible for DNA degradation (Go-
ping et al., 2003). The mouse isoform however does not efficiently process BID, so in the 
case of mice the caspase pathway represents the main mechanism of cell death (Cullen et 
al., 2007). In addition to those mentioned, additional nonapoptotic granzyme B substrates 
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have been discovered (N. J. Waterhouse et al., 2006).
In addition to perforin and granzyme, the granules contain other lytic components 
such as granulisin, which is expressed only in humans and has antimicrobial function 
(Krensky & Clayberger, 2009). Other components are involved in the protection against 
the effects of perforin and granzyme, so that the CTL are not affected by the content of their 
own granules. Calreticulin, for example, maintains perforin in its inactive conformation by 
sequestering Ca2+ ions (Andrin et al., 1998). Serpins are inhibitory proteases that can block 
the action of granzymes (Sun et al., 1996). Some cathepsins in addition to their lysosomal 
function are important in the context of lytic granules. Cathepsin C is responsible for the 
processing of granzymes, while cathepsin B can cleave and inactivate them (Balaji et al., 
2002). Other proteins present in the granules are the before mentioned serglycine, and Fas 
ligand that collaborates in cell death (Lieberman, 2003).
1.3. The control of the immune response 
The effector responses of the immune system are a powerful weapon that must be 
regulated by various mechanisms, to return to homeostasis once its function is finished and 
to avoid damages in the organism. In addition, mechanisms of tolerance are established 
so that the components of the immune system capable of recognizing their own antigens 
are eliminated or lose their effector function. In the case of T lymphocytes there are cen-
tral tolerance processes (Hogquist et al., 2005), where the autoreactive T lymphocytes are 
eliminated after a process of education in the thymus. There is also a peripheral tolerance 
(Mueller,  2010),  in which  these  cells  are  inactivated  in  the  absence  of  an  inflammatory 
context due to lack of co-stimulation, what is known as anergy (Schwartz, 2003), or due to 
the action of cellular components as regulatory T cells, by suppression mechanisms. On the 
other hand, chronic exposure to the antigen can lead to a state of exhaustion, in which the 
T cell undergoes functional changes and stops responding to antigen as a protective mech-
anism of the surrounding tissues (Pauken & Wherry, 2015). Both tolerance and exhaustion 
phenomena can lead to the onset of apoptosis (Krammer et al., 2007).
1.3.1. CTL activation
The activation of  the CTL  initiates a  complex  signaling network  to allow differen-
tiation  to  effector  cells. This activation begins with TCR recognition of  specific antigens 
presented by the MHC-I complex. The CD8 co-receptor binds to this complex, and allows 
the binding of tyrosine kinase Lck belonging to the Src family kinases (Artyomov et al., 
2010). Together with another component of this family, Fyn, they phosphorylate immu-
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noreceptor tyrosine-based activation motif (ITAM) domains of the CD3 complex chains, 
where the Zap70 protein is anchored. After being phosphorylated by Lck, Zap70 activates 
and phosphorylates scaffold LAT and SLP-76 (Jordan et al., 2003). Phospholipase C (PLC)
γ binds to this complex, which will be activated by the Itk protein of the Tec family kinases 
(Schaeffer et  al.,  1999). Phospholipase activity will  convert phosphatidylinositol 4,5-bis-
phosphate (PIP2), a membrane phosphoinostide, into diacylglycerol (DAG) and inositol 
1,4,5-trisphosphate (IP3) (Smith-Garvin et al., 2009) (Figure 2).
 These second messengers initiate three signaling pathways. On the one hand, IP3 
will open channels of Ca2+ from the endoplasmic reticulum and plasma membrane, produc-
ing an increase of Ca2+ concentration in the cytosol. After binding to calmodulin, it will ac-
tivate the phosphatase calcineurin that will dephosphorylate the nuclear factor of activated 
T-cells (NFAT) transcription factor, allowing its nuclear translocation (Hogan et al., 2003). 
On the other hand, DAG will participate in two signaling pathways. The Ras guanyl-releas-
ing protein (RasGRP) is able to bind to this second messenger, and acts as a guanine nucle-
otide exchange factor (GEF) of the Ras G protein, which is activated by binding to GTP. Ras 
initiates activation of the MAP kinases cascade, resulting in translocation to the nucleus of 
Fos, a component of the activator protein 1 (AP-1) transcription factor (Genot & Cantrell, 






























Figure 2: Main signaling pathways dependent on TCR activation
After the stimulation of TCR, a signaling cascade is triggered, activating PLCγ. 
The production of IP3 involves the activation of the transcription factor NFAT, 




its translocation into the nucleus (S. Paul & Schaefer, 2013).
For a complete T cell activation, all pathways need to be implemented. Transcription 
factors are involved in the expression of genes such as interleukin (IL)-2, a cytokine respon-
sible for lymphocyte proliferation. Deficient signaling of DAG-dependent pathways versus 
Ca2+ dependent pathways may lead to a state of inactivation or anergy (Zheng et al., 2008).
1.3.2. Immune checkpoints 
T lymphocytes express a series of activating or inhibiting receptors that help mod-
ulate  the effector  response. These are proteins, usually  expressed  in plasma membrane, 
which either limit co-stimulatory signals or help to the termination of the peripheral T cell 
responses. They have been called immune checkpoints, highlighting cytotoxic T-lympho-
cyte protein 4 (CTLA-4) and programmed cell death protein 1 (PD1), although there are 
a large number of receptors and ligands with similar functions that are less understood 
(Pardoll, 2012) (Figure 3).
The CTLA-4 receptor is expressed on T lymphocytes at 24-48h after activation (Lins-
ley et al., 1992). After recognition of the antigen presented by MHC-I by TCR, the lym-
phocyte needs a co-stimulatory signal to become activated, which is usually CD28. This 
receptor is able to bind to the CD80 and CD86 receptors of the antigen-presenting cell, 






















Figure 3: Negative regulation of TCR signaling
Different proteins participate in the negative regulation of TCR-dependent 
signaling. The CTLA-4 receptor binds to CD80 and CD86, competing with the 
CD28 co-receptor. In addition, it activates phosphatases which reverse the ac-
tivation of TCR signaling cascade proteins. The PD1 receptor binds to its PD-
L1 and PD-L2 ligands, and also activates inhibitory phosphatases through its 
cytoplasmic tail containing ITIM and ITSM domains, such as SHP-1 and SHP-2. 
DGK would participate converting the DAG into PA, attenuating the signaling 
dependent on this second messenger, such as the RasGRP and PKC pathways. 
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lymphocyte. CTLA-4 is able to bind to CD80 and CD86 in such a way that it is capable of 
preventing binding to CD28 by competition, and also generates inhibitory signals (Linsley 
et al., 1994). CTLA-4 signaling is subjected to controversy, since although domains of tyro-
sine phosphorylation in the cytoplasmic sequence that could serve as binding to phospha-
tases such as Src homology region 2 domain-containing phosphatase (SHP)-2 have been 
detected, it has been questioned whether they are really necessary and can fulfill this func-
tion (Walker & Sansom, 2015). In fact it is thought that the role of these domains could be 
involved in subcellular localization (Shiratori et al., 1997), since the CTLA-4 produced by 
the cell is initially stored in intracellular vesicles until its accumulation at the immune syn-
apse (Egen & Allison, 2002). The importance of CTLA-4 in tolerance processes is observed 
in CTLA-4-deficient mice, which suffer from a lethal autoimmune and lymphoproliferative 
syndrome (P. Waterhouse et al., 1995).
The PD1 receptor is expressed in T cells after sustained activation in peripheral tis-
sue (Agata et al., 1996). It binds to ligands programmed cell death 1 ligand (PD-L)1 and 
PD-L2, which in the first case is expressed in a large number of cells and in the second in 
antigen-presenting cells during inflammation (Keir et al., 2008). Thus, when a T lympho-
cyte is activated for a prolonged time it expresses the PD1 receptor, and the contact with 
self-cells and/or other activated T cells favors its exhaustion avoiding excessive response 
(Barber et al., 2006). The receptor contains two tyrosine phosphorylation immunoreceptor 
tyrosine-based inhibitory/switch motif (ITIM and ITSM) domains that bind SHP-1 and 
SHP-2 phosphatases that inhibit the TCR signaling cascade after ligand binding (Sheppard 
et al., 2004). In addition, the PD-L1 ligand can bind to the CD80 receptor expressed on T 
lymphocytes, and induce down-regulation (Butte et al., 2007). In contrast, in the case of 
regulatory T cells the binding of the PD1 receptor to its ligands causes activation (Francisco 
et al., 2009). Mice deficient in this receptor undergo autoimmunity, due to impaired toler-
ance but not as strong as in the case of CTLA-4 deficiency (Nishimura et al., 1998).
In addition to the previous membrane receptors, there are other less known immune 
checkpoints that also act diminishing the effector response. Among them is BTLA, which 
is activated by binding to HvEM. HvEM is a molecule that exerts a complex regulation, 
since it can also inhibit or activate T cells binding to CD160 and LIGHT receptor, respec-
tively (Pasero & Olive, 2013). Another immune checkpoint is LAG3, with high expression 
in activated T cells, able to binding mainly to MHC-II, and that causes the inhibition of the 
effector response. It is also expressed in regulatory T cells, which can inactivate MHC-II-ex-
pressing cells as dendritic cells (Andrews et al., 2017). The TIM-3 receptor also inhibits the 
action of CD8 T cells on binding to galectin-9 (Zhu et al., 2005), as well as KIR receptors, 
capable of binding to MHC, which in addition to expressing NK cells have an inhibitory role 
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in T cells (Mingari et al., 2005). 
1.3.3. Diacylglycerol kinases as negative regulators of immune response
The diacylglycerol kinases (DGK) constitute a family of enzymes conserved through-
out the evolution. These lipid kinases catalyze the conversion of DAG into phosphatidic acid 
(PA), a reaction dependent on ATP consumption, and are involved in cell signaling process-
es dependent on these metabolites, and in the phosphoinositide cycle regulation (Figure 
3). Ten isoforms are currently known in mammals with a specific distribution according to 
tissues, and remarkably functions like their role in the immune and nervous systems. They 
share a catalytic domain with a specific ATP-binding sequence, and atypical cysteine-rich 
zinc finger C1 domains that facilitate enzyme migration from the cytosol to the membrane. 
In addition, each isoform has its own regulatory domains that allow them to be grouped 
into 5 types, and which suggest a fine regulation for these enzymes (Mérida et al., 2008).
In the immune system the DGKα and DGKζ isoforms are highly expressed, especially 
in T cells (Sanjuán et al., 2001; Zhong et al., 2002). They play an important role in the regu-
lation of T cell activation by reducing DAG levels and attenuating signaling cascades depen-
dent on this molecule. In the basal state these enzymes remain in the cytosol in its inactive 
form. DGKα has at its N-terminus an inhibitory region (Sanjuán et al., 2001) with recoverin 
and EF hands domains, able to bind to Ca2+. Thus, Ca2+ release promoted by TCR signaling 
facilitates a conformational change favoring DGKα activation. DGKα phosphorylation by 






et al., 2003) facilitates its sustained membrane binding and activation (Santos et al., 2002).
DGK activity limits DAG-dependent regulation of Ras activation. In T lymphocytes, 
the GEF of Ras RasGRP binds DAG, and activates the Ras/extracellular signal regulated 
kinase (Ras/ERK) pathway allowing the activation of Fos of the AP-1 transcription factor 
(Ebinu et al., 1998). Both DGKα and DGKζ limit the activation of this pathway by reducing 
DAG levels (Sanjuán et al., 2003; Zhong et al., 2002). In fact, mouse models deficient in 
these enzymes corroborated an increase in ERK activation (Olenchock et al., 2006; Zhong 
et al., 2003). In addition to this axis, the activation of the PKCθ-dependent transcription 
factor NF-κB is preferentially affected by DGKζ (Ávila-Flores et al., 2017). Both axes are re-
quired together with Ca2+-dependent NFAT activation for complete gene expression during 
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T lymphocyte activation, and its attenuation leads these cells to a state of anergy (Macián 
et al., 2002). In agreement with this, DGKα and DGKζ deficient mice are anergy resistant.
DGK activity not only regulates transcription but also contributes to the regulation 
of immune synapse formation During the formation of the immunological synapse, the 
accumulation of DAG in the contact membrane region is essential to allow correct polariza-
tion of the secretory machinery (Quann et al., 2009), thanks to the action of several PKCs 
(Quann et al., 2011). DGKζ is able to translocate to the synapse, where it regulates DAG 
levels and production of PA predominantly unlike DGKα (Gharbi et al., 2011; Joshi et al., 
2013), and participates in the polarization of MTOC to the immune synapse during the for-
mation of the cytotoxic immune synapse (Andrada et al., 2016). It also limits translocation 
of PKCα, regulator of signaling by the Ras/ERK axis (Gharbi et al., 2013), and of PKCθ, 
associated with CD28-dependent signaling (Ávila-Flores et al., 2017). In CD4 T cells, DGKα 
participates in the formation of the DAG gradient by being preferentially located around 
the synapse (Chauveau et al., 2014). DGKα also plays a role in the secretion of exosomes 
expressing FasL (Alonso et al., 2011), another mechanism of CTL to induce cell death.
1.3.4. Regulatory T cells
Regulatory T cells (Treg) are CD4 T cells, which are involved in maintaining tolerance 
towards self antigens by suppressing immune responses. They are characterized by high 
expression of the α chain of the IL-2 receptor (CD25), and expression of the forkhead box 
P3 (Foxp3) transcription factor. In fact the mutation of these genes causes the lack of Treg, 
leading to lymphoproliferative autoimmune syndromes (Brunkow et al., 2001; Sadlack et 
al., 1995). Treg originate in the thymus, from CD4 cells whose TCR recognizes their own 
peptides. These cells are known as natural regulatory T cells (nTreg). Treg can also be gen-
erated from naïve CD4 T cells in the periphery by the action of cytokines such as transform-
ing growth factor (TGF) β and are known as induced regulatory T cells (iTregs) (Chen et al., 
2003). This occurs as a mechanism of tolerance when self-antigens are recognized in the 
absence of an innate immune response. The maintenance of Treg depends on the presence 
of IL-2, which also favors the expression of Foxp3 (Malek, 2003).
Treg affect both activation and effector functions of T cells by several mechanisms. 
One  is  the production of  immunosuppressive  cytokines  such as TGFβ,  IL-35 and  IL-10. 
Another is the suppression of dendritic cells by the action of the CTLA-4 molecule constitu-
tively expressed in the membrane. CTL-4, when bound to CD80, prevents proper activation 
and induces indoleamine 2,3-dioxygenase (IDO) expression, which depletes tryptophan 
and compromises the T-cell response (Grohmann et al., 2002). The IL-2 uptake by Treg can 






The term cancer encompasses a group of diseases characterized by the uncontrolled 
growth of cells that escape the mechanisms of homeostasis that assure the balance in the 
cellular proliferation. This is because these cells undergo a series of progressive genetic 
modifications that make them acquire, when affecting oncogenes, or lose, for tumor sup-
pressor genes, certain functions. Uncontrolled cell growth or neoplasia causes a tumor 
mass, which can lead to cancer if it acquires invasive characteristics. As this process of 
malignancy progresses, the cells end up colonizing other tissues, known as metastasis. The 
tumor is a complex structure, in which tumor cells are surrounded by other cell types, and 
where angiogenesis occurs and the infiltration of components of the immune system is de-
tected (Hanahan & Weinberg, 2011).
Early theories supported a process of surveillance of the immune system against tu-
mors, in which the cells of the immune system would patrol the body in search of tumors 
for its elimination. In fact, the existence of immunodeficiencies in mice increases the risk of 
the appearance of certain specific types of tumors (Dunn et al., 2002). Currently this con-
cept has evolved towards that of immunoediting, which is divided into three phases. In the 
phase of elimination, the immune system reacts against tumor cells and can achieve tumor 
eradication. If this does not happen, an equilibrium phase is reached where mutations ap-
pear in the tumor cells and the most resistant cells are selected. In the escape phase some 
cellular variants finally evade the immune mechanisms and grow uncontrollably (Dunn et 
al., 2002).
Nonetheless, in many cases tumor cells are poorly immunogenic, and the immune 
system is not able to differentiate them from normal cells. When presentation occurs, an-
tigens can be classified  into  two categories. Tumor specific antigens  (TSA) comprise  the 
product of genetic mutations, alterations of membrane glycolipids and/or viral antigens 
when the tumor is produced by a virus. Tumors may express antigens of other cell types 
(tumor-associated antigens, TAA), like antigens of fetal origin that are not expressed in 
adult, or characteristic of immune privileged niches like the melanocyte tyrosinase (vign-
eron, 2015). Even in the case of antigenic recognition, tumors evade the immune response 
taking advantage of the mechanisms of peripheral tolerance that are used for healthy cells 
to avoid self-recognition and/or damage by sustained inflammatory conditions. The lack 
of appropriate co-stimulation and the immunosuppressive tumor environment favor tol-
erance induction of T cells. In some cases, tumor structure may prevent the correct access 
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of cells of the immune system, which precludes its antitumor action (Salmon et al., 2012).
1.4.1. Cellular components of tumor microenvironment 
The analysis of solid tumor environment reveals in many cases the presence of in-
filtrated T lymphocytes. CTL represent the main population that fights against the tumor. 
The presence of tumor-infiltrating-lymphocytes (TIL) in the tumor is in fact considered a 
sign of good prognosis for cancer outcome (Galon et al., 2006; Gooden et al., 2011). T lym-
phocytes need to recognize tumor antigens presented in tumor cells to eliminate them. It is 
not well known how the tumor initially triggers this immune response. Dendritic cells are 
proposed to collaborate by presenting tumor antigens, captured for example from dead tu-
mor cells. Another possibility is that of detection by dendritic cells of associated molecular 
patterns generated during tumor growth (Hernandez et al., 2016). Once these cells present 
the antigens to T cells these would be recruited to the tumor thanks to the production of 
chemoattractant molecules as several chemokines in the tumor environment (Harlin et al., 
2009).






et al., 2015). NK cells also represent another mechanism of antitumor action. These cells 
can act against tumor cells when, as a mechanism for T cell evasion, they lose the expres-
sion of MHC-I molecules. In addition, some tumors may express NKG2D ligands, a NK cell 
activating receptor, which trigger its action (Waldhauer & Steinle, 2008).
Macrophages present in tumor microenvironment may either promote or suppress 
tumor growth. M1 macrophages are activated by IFNγ and receptors of molecules contain-
ing damage-associated molecular patterns, and exert an antitumoral role. M2 macrophages 
on another hand produce molecules that induce angiogenesis such as vascular endothelial 
growth  factor  (VEGF), and TGF-β. TGF-β as well as  the production of  the  IL-10  immu-
nosuppressive cytokine can also reduce the T cell response (Chanmee et al., 2014). Other 
cells related to the macrophage lineage are the myeloid-derived suppressor cells (MDSC). 
These are hematopoietic precursors of myeloid cells such as macrophages, dendritic and 
granulocytes, which in the tumor environment differentiate towards an immunosuppres-
sive phenotype. MDSC produce inhibitory IL-10 and also free radicals that can damage T 
lymphocytes. They also produce the enzyme IDO, what induces the development of Treg, 
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exerting an inhibitory action on T cells (Monu & Frey, 2012). Tumor can also recruit nTreg 
and/or favor the differentiation of iTregs (Deng, 2018).
1.4.2. Tumors trigger expression of negative regulators of immune response
The expression of immune checkpoints, whose function is to avoid self damage, also 
occurs in the tumor microenvironment and is used by cancer cells to evade the immune 
response. In the tumor microenvironment, due to low immunogenicity, the antigen-pre-
senting cells express few CD80/CD86 molecules and CTLA-4 is competing with CD28 for 
the binding of CD80/CD86, inducing T cell inhibition. Treg constitutively express CTLA-4, 
and their signaling favors their own activation (Wing et al., 2008), inhibiting T cell func-
tions. The development of antibodies  that block CTLA-4-CD80/86 binding was  the first 
treatment of immunotherapy applied to an immune checkpoint (Hodi et al., 2003). In the 
tumor microenvironment diverse cells, including tumor cells, can express the ligands PD-
L1 and PD-L2. This expression may be innate, due to an oncogenic pathway such as phos-
phatidylinositol-3-kinase-protein kinase B (PI3K-Akt) (Parsa et al., 2007), or adaptive by 
the continued action of T cells, for example via IFNγ secretion (Taube et al., 2012). TIL over 
time express PD1 and undergo exhaustion due to their binding to the ligands. This has pro-
moted the development of antibodies that block against the binding of PD1 with its ligands, 
with excellent clinical results of melanoma and other types of cancer (Balar & Weber, 2017).
The existence of a  large number of checkpoints opens  the door  to a specific  treat-
ment according to cell surface protein expression pattern of tumor cells, in addition to the 
combined therapy to increase its efficiency (Sharma & Allison, 2015). These treatments can 
be combined with the application of other immunotherapy strategies such as vaccination 
with tumor antigens to increase the immunogenicity of tumors (Farkas & Finn, 2010), or 
adoptive cell therapy with transgenic T lymphocytes with chimeric antigen receptors (CAR) 
(Kalos & June, 2013) that potentiate the activation of these cells against the tumor. The 
study of the mechanisms that control the immune system therefore involves increasing the 
chances of achieving an effective treatment against cancer.
1.4.3. The role of diacylglycerol kinases in cancer
In addition to its important role as negative control of the immune response, DGK 






activation of Src, facilitating growth and survival (Torres-Ayuso et al., 2014). In the case of 
DGKζ, the production of PA by this isoform favors the activation of mTOR, a cell growth 
regulator (Ávila-Flores et al., 2005). In addition, the decrease in DAG levels favors the ac-
tivation of the SREBP-1 transcription factor that favors the expression of lipid metabolism 
enzymes, necessary for tumor growth (Torres-Ayuso et al., 2015). In this way, both DGKα 
and DGKζ represent attractive therapeutic targets against cancer.
On the other hand, DGK also exert an important role in the immune system cells in-
filtrated in the tumor microenvironment. In fact, there is a greater expression of DGKα in 
TIL with respect to non-infiltrated lymphocytes as in the case of other immune checkpoints 




production and cytotoxic response, and tumor growth is limited (Riese et al., 2013). xeno-
graft models in DGK deficient mice show enhanced tumor rejection by DGKζ deficient CTL 
(Riese et al., 2011; Andrada et al., 2017). Furthermore, DGKζ deficiency also potentiates NK 




antitumor response and cytokine production in T cells is observed (Liu et al., 2016). The 
search for new specific inhibitors for DGK isoforms will increase the chances of finding new 
immunotherapeutic drugs against cancer.
2. Proteomics
Proteomics is the science that studies the proteome. Proteome is known as the set 
of proteins, expression product of the genome (Wilkins, 2009), present in an organism, 
tissue or cell at a given time. Its expression is dynamic in time and space, and it is subject 
to different levels of regulation. In addition, due to phenomena such as alternative splicing, 
RNA editing and post-translational protein modification, there are a much larger number 
of protein species than genes (Gstaiger & Aebersold, 2009). The level of expression of these 
proteins is changing and it does not always correlate with transcriptional and translational 
regulation, so messenger RNA levels do not always correspond to protein levels (Schwan-
häusser et al., 2011). Thus proteomic studies can provide more accurate information on 




proteome, whose major paradigm is the human proteome project (Legrain et al., 2011). 
In addition, it  is possible to quantitatively analyze the differences in expression between 
samples, as well as to detect post-translational modifications and interactions of a given 
protein. With all these possibilities proteomics can provide answers to biological prob-
lems such as the complete characterization of proteomes and clinical problems, such as the 
search for biomarkers that can provide information about the state of a disease or can serve 
as therapeutic targets (Aebersold & Mann, 2016).
2.1. Mass spectrometry-based proteomics
Although there are proteomic approaches such as the use of protein microarrays (Po-
etz et al., 2005), advances  in  the field of proteomics  rely mainly on  the development of 
mass spectrometry (MS) (Domon & Aebersold, 2006). A mass spectrometer is able to mea-
sure the mass-to-charge ratio (m/z) of ionized molecules, and in proteomics, we generally 
refer to the peptides obtained from enzymatic digestion of proteins. Selective mass and 
fragmentation profile of proteolysed peptides can be predicted in silico and used as a da-
tabase to search experimental observations by mass spectrometry. From this information 
the proteins of a proteome can be identified. There are many types of mass spectrometers 
that should be employed according to the type of analyte to be measured, the complexity 
of the samples, their matrix or the requirement for quantification. Most proteomics-based 
methodologies are done using a bottom-up approach, although other alternative strategies 
are gaining much interest and becoming invaluable tools to gain in speed, quantitation 
and robustness, such as data-independent acquisition (DIA), multiple reaction monitoring 
(MRM) and parallel reaction monitoring (PRM) methods (T. Shi et al., 2016).
Mass spectrometers consist of an ion source where the sample is ionized and gains a 
charge which will enable it to enter the mass spectrometer, a mass analyzer that separates 
the ionized molecules according to their m/z, and a detector that captures and records the 
intensity of the ions. The generated information is analyzed and compared with databases 
with the help of bioinformatic software to elucidate the protein composition of the original 
sample. Mass spectrometry can achieve a high sensitivity and wide dynamic range, capa-






Among the sources of ionization used in proteomics are those that produce a soft 
ionization, which prevent the molecule from rupturing, and which do not require sam-
ple volatilization such as matrix-assisted laser desorption/ionization (MALDI) (Karas & 
Hillenkamp, 1988) and electrospray ionization (ESI) (Fenn et al., 1989). The latter is the 
ionization method most used in data-dependent acquisition (DDA) or global proteomics 
profiling, also known as shotgun proteomics. ESI allows positively or negatively charged 
ionization of peptides that have been separated in liquid phase. For this, the high-perfor-
mance liquid chromatography (HPLC) flow is passed through a thin needle where a high 
electric potential difference of 0.5-4.5kV is applied (Glish & Vachet, 2003). This normally 
generates multiply charged ions. Metabolite charging allows a reduction in the m/z permit-
ting large peptides to be within the mass range of the equipment. The electric field induces 
in the fluid the formation of a Taylor cone and the ejection of liquid which is dispersed, gen-
erating many droplets in a spray due to the repulsion of charges (Taylor, 1964). The result is 
the production of an aerosol, directed into the equipment due to the internal high vacuum. 
2.1.2. Mass analyzers
After ionization, the ion m/z is evaluated by mass analyzers, such as time-of-flight 
(TOF), quadrupole, ion trap and cyclotron resonance (Yates et al., 2009). In the case of 
TOF (Weickhardt et al., 1996), the ions go through a vacuum tube and are detected by 
a time detector located at the end of the tube. The ions with higher m/z take longer to 
travel the same path. In the case of the quadrupole mass analyzer (W. Paul & Steinwedel, 
1953), it consists of four elongated rod-shaped electrodes placed in parallel, delimiting a 
space through which the ions cross (Hoffmann & Stroobant, 2007). These electrodes are 
subjected to radiofrequency and direct current voltages, which allow to select a narrow 
range of mass of the ions that will cross the quadrupole to the detector, and to deflect out 
the unwanted ions. By changing the radiofrequency voltages, it is possible to select ions of 
different m/z that will reach the detector sequentially.
2.1.3. Tandem mass spectrometry (MS/MS)
In the classical proteomic approach, the proteins in the sample are digested by using 
a proteolytic enzyme that cleaves the protein into peptide fragments. Trypsin is one of the 
most commonly used digesting enzymes in proteomics since it is able to generate peptides 




theoretical values obtained by in silico digestion of the proteome of the species of interest. 
By means of a computer application, the most probable peptides are assigned to these m/z, 
and in turn are targeted to proteins containing these peptides (Pappin et al., 1993). When a 
complex protein mixture is analysed, it becomes impossible to identify a protein based on 
peptide mass. Therefore, in a shotgun analysis of complex proteomes, tandem mass spec-
trometry (MS/MS) is used, in addition to measuring the m/z of the precursor peptides or 
ions, to fragment and analyze the m/z of the ions product. This fragmentation spectrum is 
compared with in silico generated spectra from tryptic peptides, to find out the mass and 
sequence of the original peptide (Domon & Aebersold, 2006) (Figure 4).
2.1.4. Sample preparation and separation of proteins
Although new mass spectrometers can deal with complex samples, best results are 
obtained and deeper coverage of the proteome is achieved when samples are sub fractionat-
ed using orthogonal approaches. Peptide fractionation may be employed to obtain smaller 
subproteomes than a total proteome (Dreger, 2003). This is critical to avoid ion suppres-
sion in the mass spectrometer. Sample separation can be done at protein or peptide level. 
Protein separation can be done based on its molecular weight or isoelectric point, such 
as electrophoresis in polyacrylamide gels in one or two dimensions (1D- and 2D-PAGE), 
which allow a separation by molecular mass. In the case of 2D-PAGE (O’Farrell, 1975) an 
isoelectric point separation is performed. In this manner a collection of spots in a gel is ob-












Figure 4: Tandem mass spectrometry
Simplified scheme of a MS/MS experiment in data-dependent acquisition 
configuration in a QTOF type spectrometer. A) In full scan mode all ionized 
peptides pass through the first quadrupole (Q1), and arrive without fragmen-
tation to the TOF, where they are separated according to m/z and detected. 
B) In MS/MS mode the Q1 filters ionized peptides in a determined interval of 
m/z, which are fragmented in the second quadrupole (Q2) by means of CID, 
before passing to the TOF. Adapted from (Domon & Aebersold, 2006).
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phy (Lescuyer et al., 2004). Protein separation can also be carried out based on its function 
or selective characteristics, such as immunoprecipitation, subcellular fractionation or pull-
downs to enrich proteins based on protein-protein interactions. The method of separation 
will depend on the characteristics of the sample for a higher peak resolution. In addition, 
sample complexity can be reduced at peptide levels. Typically, peptides can be separated 
based on their biochemical characteristics such as mass, charge or hydrophobicity. 
2.1.5. Quantitative Proteomics





(DIGE) (Ünlü et al., 1997) were initially used, the implementation of shotgun techniques 
has required the development of new quantification techniques based in mass spectrome-
try, including label-free (Neilson et al., 2011) and especially isotopic labeling methods. In 
techniques with differential isotopic labeling, the proteins or peptides are modified with the 
addition of different isotopes for each treatment or mass tags. The physicochemical prop-
erties of the peptides with or without labeling are identical, whereby the chromatography 
can be performed together. MS analysis will detect m/z differences between treatments and 
allows relative quantification (Gygi et al., 1999; Ross et al., 2004; Thompson et al., 2003).
Another approach is metabolic labeling, in which the incorporation of isotopic la-
beling occurs during the metabolism of the original sample, in the case of cells in culture 
or even in complex organisms (Gouw et al., 2010). Thus, technical variability during the 
sample processing can be reduced, since samples can be pooled from the initial steps of the 
preparation. One of most used techniques is stable isotope labeling by amino acids in cell 
culture (SILAC) (Ong et al., 2002). This labeling is usually performed by adding 13C-la-
beled lysine and arginine amino acids to the culture medium or diet. The choice of these 
amino acids is because they are the target of trypsin activity, so that all the peptides gener-
ated contain labeled amino acids. Quantification is carried out comparing peptide doublets 
in MS mode (Mortensen et al., 2010). The samples are divided into light and heavy depend-
ing on the medium used, although it is possible to compare more than two samples using 
amino acids with different labeling (Tzouros et al., 2013). The disadvantage of metabolic 
labeling methods is that they can be only used in proliferating samples to allow heavy ami-




this limitation, the use of SILAC labeled cells as a spike-in standard can solve this problem, 
what is known as super-SILAC (Ishihama et al., 2005).
2.1.6. Membrane proteomics
Plasma membrane proteins contain hydrophobic regions that anchor or associate 
with the lipid bilayer, in many cases passing through the membrane one or several times, 
which causes a very stable interaction. These proteins also contain other hydrophilic re-
gions that contact both external and internal side and allow interaction with cargoes, li-
gands and other proteins. Due to the presence of hydrophobic regions, membrane proteins 
are difficult to solubilize and possess few charged lysine and arginine for trypsin cleavage 
and they are often found at low abundance (vit & Petrak, 2017). Traditional techniques 
for enrichment of these proteins rely on subfractionations to reduce the complexity of the 
proteome and to remove other more abundant proteins from other cellular compartments. 
These methods may include ultracentrifugations, density gradients or separation with dif-
ferent matrices to isolate hydrophobic proteins from total lysates (L. Zhang et al., 2005). 
In these cases, there may be problems in differentiating proteins from either plasma mem-
brane or other endomembranes.
There are other  approaches  to  specifically  isolate proteins  from  the plasma mem-
brane, mainly directed to the hydrophilic extracytosolic domains. One example is labeling 
with biotin derivatives of cell surface proteins (Peirce et al., 2004). These reagents have the 
ability to bind to the primary amino groups of the lysine and N-terminal side chains. After 
the cell lysate, the labeled molecules are isolated with streptavidin bound to different ma-
trices, taking advantage of the great affinity it has with biotin, of the highest ones without 
being a covalent bond (Elia, 2008). Another strategy is the cell shaving, in which the intact 
cell is subjected to the action of a protease to cut out the protein fragments from the outer 
cell side, for example proteinase K (Speers et al., 2007) or phospholipase D (Elortza et al., 
2006). The analysis of these fragments provides topological information about proteins. 
The disadvantage of this technique is that the protease can damage the cells and lead to cell 
lysing and release also cytosolic proteins.
Most of membrane proteins have on their outer side some type of glycosylation. One 
strategy for the purification of membrane proteins has focused on the isolation of N-linked 
glycoproteins by using lectins that bind to their glycogenic part as concanavalin A or wheat 
germ agglutinin,  since  the  isolation  of O-linked  glycoproteins  by  lectins  is  less  effective 
(Pan et al., 2011). Another approach is the use of hydrazide-derivatives of biotin, which re-
act with the glucidic portion previously treated with an oxidizing agent. These studies also 




part prior to analysis by mass spectrometry (Wollscheid et al., 2009).
2.1.7. Bioinformatic analysis proteins
Bioinformatics has facilitated the analysis of the large amount of data obtained in 
shotgun proteomic experiments, helping with their biological interpretation (Carnielli et 
al., 2015). In a first case where the detected proteins have not been characterized it is possi-
ble to use applications capable of extracting biological information from protein sequence 
(Juncker et al., 2009). Some applications analyze regions of hydrophobicity and can predict 
transmembrane domains using hidden Markov models (Krogh et al., 2001). The problem is 
that being a membrane protein does not always imply that it belongs to the cell surface. If 
the protein has been described in previous studies, the text mining applications can analyze 
the scientific literature written in natural language and try to search for information about 
proteins on their properties and interactions, and translate them into a structured language 
(Rebholz-Schuhmann et al., 2012).
In general, the interpretation of a shotgun proteomic experiment will require the use 
of a database where previously the biological information of the proteins has been cata-
loged in a standardized way and with a controlled vocabulary that uniquely identifies the 
properties of a protein (Calderón-González et al., 2016). One of the most important ex-
amples is UniProt, a database where researchers store the identified proteins (Apweiler et 
al., 2004). A further step is the use of hierarchical languages such as ontologies, like Gene 
Ontology (GO) (Ashburner et al., 2000). This project describes the proteins according to 
three categories: cellular component, molecular function and biological process. GO terms 
within each category are hierarchized at multiple levels, from the most general to the most 
specific, and the type of relationship between parent and child terms is specified.
There are a large number of computer applications capable of retrieving information 
from these databases to interpret biological information (Huang et al., 2009a). Enrichment 
analyzes look at a list of proteins those GO terms that are over- or underrepresented, as in 
the case of DAvID (Dennis et al., 2003). It also groups clusters of proteins belonging to 
similar categories. Another application used for these purposes is GSEA, focused on quan-
titative genomic analysis between samples (Subramanian et al., 2005). To facilitate the vi-
sualization of the results, applications such as Cytoscape allow representing the proteins in 
an interaction map (Shannon et al., 2003). In this Cytoscape framework, applications have 
been developed to analyze and represent enriched GO categories, including BinGO (Maere 
et al., 2005), EnrichmentMap (Merico et al., 2010), with ClueGO (Bindea et al., 2009) and 





CTL perform immunovigilance and develop a response against tumor cells. However, 
this response may be compromised due to the regulation of tumor microenvironmental 
factors or homeostatic mechanisms of the T lymphocyte itself. DGKζ is a member of the di-
acylglyerol kinase family that regulates the levels of DAG and PA. DGKζ has been shown to 
participate in the activation of T cells and particularly on the cytolytic response of CTL. The 
signaling pathways dependent on DGKζ have been well studied as well as their impact on 
the expression of some proteins involved in tumor recognition. However, a comprehensive 
and unbiased study characterizing the changes in the proteome of CTL in response to DGKζ 
activity has not yet been carried out.
Our main objective was the characterization of the proteome of CTL, with special 
interest in proteins expressed at cell surface, which are know to be critical for cell-cell com-
munication. With this in mind, we focused on plasma membrane proteins for the search of 
specific markers of tumor response.
To achieve this goal, we set several specific objectives:
1.  Develop methods of enrichment of plasma membrane proteins, and other cell 
compartments, to perform shotgun mass spectrometry analysis.
2.  Determine the impact of DGKζ activity on protein expression changes in CTL:


















Ovalbumin (OVA) (257-264) AnaSpec
Phorbol 12-myristate 13-acetate (PMA) Sigma-Aldrich
Phenylmethylsulfonyl fluoride (PMSF) Sigma-Aldrich
Sodium fluoride (NaF) Sigma-Aldrich
Sodium orthovanadate (Na3VO4) Sigma-Aldrich
β-glycerophosphate Sigma-Aldrich
Dimethyl sulfoxide (DMSO) Sigma-Aldrich
Acrylamide/Bis Solution, 29:1 (30%) Bio-Rad
Paraformaldehyde (PFA) Sigma-Aldrich
poly-D,L-Lysine Sigma-Aldrich
LysoTracker Green (LTG) Life Technologies
Trypsin Sigma-Aldrich
Table 2: Antibodies and their corresponding manufacters
Antibody Supplier
ERK Cell Signaling Technology
GM130 BD Biosciences
Histones Millipore
p-AKT S473 Cell Signaling Technology
p-ERK Y202/T204 Cell Signaling Technology
PLCγ-1 Millipore






The Jurkat cell line (ATCC TIB-39, clone E6-1) was grown below 5·105 cells/mL in 
Dulbecco’s  Modified  Eagle  Medium  (DMEM)  (BioWhittaker)  supplemented  with  10% 
heat-inactivated fetal bovine serum (FBS) (Gibco) and 2mM of L-glutamine (Invitrogen). 
Primary mouse lymphocytes were cultured in Roswell Park Memorial Institute (RPMI) 
1640 medium (BioWhittaker) supplemented with 10% FBS, 2mM glutamine and 50µM of 
β-mercaptoethanol (BioWhittaker). All cells were grown at 37°C and 5% CO2.




10mM HEPES. For the light condition 0.4mM L-arginine and 0.8mM L-lysine were added, 




Two replicates with reverse labeling were performed, so that in one of them the pri-
mary wild type (WT) mouse lymphocytes were cultured in light condition and the DGKζ-/- 
in heavy condition, and in the other the WT cells were cultured in heavy condition and the 
DGKζ-/- cells in light condition. During the activation of the lymphocytes with OvA peptide, 
they were cultured in standard medium, while once in the proliferation phase with IL-2, 
they were transferred to SILAC medium for 5 days.
Antibody Supplier
β-actin Sigma-Aldrich
anti-mouse IgG horseradish peroxidase (HRP) Dako











All the procedures used for the mouse work were approved by the CSIC Ethics Com-
mittee. DGKα-deficient mice were  donated  by Dr. Xiao-Ping  Zhong  of Duke University 
Medical Center (Durham NC), and DGKζ-deficient mice by Dr. Gary Koretzky of the Uni-
versity of Pennsylvania (Philadelphia PA). These mice were crossed with OT-I strains to get 
OT-I mice DGKα-/- and OT-I DGKζ-/- at the CNB animal facility.
6. Primary mouse lymphocytes isolation and activation
Six- to fourteen- week-old mice were used to obtain primary mouse lymphocytes. 
Lymph nodes or spleens were removed and homogenized in a cell strainer (Becton Dick-
inson). The cells were resuspended with phosphate-buffered saline (PBS) for counting. In 
the case of spleens, erythrocyte lysis buffer (0,154M NH4Cl, 10 mM KHCO3, 0.1 mM eth-
ylene diamine tetraacetic acid (EDTA) pH 7.4) was additionally used. Finally, after wash-
ing with PBS, 105 cells/mL were plated in culture medium for stimulation. For OT-I mice, 
SIINFEKL 10nM peptide  from ovalbumin (OVA257-264)  (AnaSpec) was added, or 2µg/
mL concanavalin A in the case of non OT-I mice. After 72h, cells were stimulated with IL-2 
(100U/mL) during 4 days.
7. Western blot








transferred  from the gel  to a polyvinylidene fluoride  (PVDF) membrane  (BioRad). After 
incubation with the corresponding primary antibodies, it was incubated with a second-
ary antibody coupled to peroxidase, which was revealed by chemiluminescence of the ECL 
(Amersham) reagent collected by autoradiography.
8. Flow cytometry






ter. The analysis was performed using FlowJo v10 (Tree Star) software.
9. Confocal microscopy
To evaluate the permeability of the biotins, Jurkat cells are labeled with Sulfo-NHS-Bi-
otin or Sulfo-NHS-SS-Biotin. The cells were plated in crystals coated with poly-D,L-Lysine 





samples were washed with PBS and mounted with Aqua Poly/Mount (Polysciences). The 
images were acquired with an Olympus Fluoview Fv-1000 confocal microscope and pro-
cessed using Image J software.
10. Lysotracker green staining
The lysosomes staining was done with LTG, always applied as the last stain. The cells 
were resuspended in tempered medium at 37°C with the probe, at 50, 70, 100 or 200nM 
depending on the treatment. Incubation time was 2 or 30 minutes. The cells were kept in 
RPMI or switched to PBS or HBSS and were immediately analyzed by flow cytometry or 
confocal microscopy. In the case of confocal microscopy, stained cells were incubated in 
chambers previously coated with poly-D,L-Lysine for 5 minutes before visualization.
11. Biotinylation
For the proteomics experiments, about 5·107 and 108 cells were collected for Jur-
kat and differentiated CTL experiments, respectively. For the study of the PMA effect, this 
molecule was added at 0.1µg/mL or DMSO for the control treatment for 4h, 37°C. The cells 
were washed twice with cold PBS and sulfo-NHS-biotin or sulfo-NHS-SS-biotin (Pierce) 
was added at 1mg/mL for 20min, 4°C in agitation. Afterwards, two washes were performed 













ration using SDS-PAGE, while reserving 1/10 of the volume for further analysis by western 




Subcellular fractionation was performed using the ProteoExtract kit (Calbiochem) 
following the manufacturer’s instructions as described (Abdolzade-Bavil et al., 2004). 
Briefly, the cells were sequentially subjected to a series of lysis buffers and centrifugations 
to separate the cytosol, membrane, nucleus and cytoskeleton fractions. These fractions were 
prepared for separation by SDS-PAGE or RP-HPLC, as well as for western blot analysis.
















Figure 5: Biotinylation workflow
The cells of the different treatments were incubated with biotin, and then 
lysed to isolate the membrane proteins by pull-down with neutravidin. The 
lysate was separated by 1D SDS-PAGE, and bands were extracted for digestion 
with trypsin. The mixture of tryptic peptides was analysed by LC-ESI-MS/MS, 






In the case of biotinylation, the proteins from the pull down with NeutrAvidin were 
eluted in sample buffer and separated by SDS-PAGE. In the case of subcellular fraction-
ation, about 100µg of protein was loaded from each fraction in the gel. After electrophore-
sis, the gel was stained with coomassie brilliant blue (QuickCoomassie, Generon). Sixteen 
bands were cut and transferred to a 96-well plate for further automatic in-gel digestion 
using a Proteineer DP (Bruker Daltonics). The bands were washed with 50mM ammonium 
bicarbonate, and then washed and dried with 100% ACN. The bands were then reduced and 
alkylated adding 10mM DTT and 50mM IAM respectively, and were washed with 50mM 




From the subcellular fractions of cytosol, membranes and nucleus, a protein pre-
cipitation was carried out by sequentially adding methanol, chloroform and water (4:1:3). 
After centrifuging (15000g, 2min), the supernatant was discarded, and after washing with 
methanol the pellet was centrifuged again and recovered. It was then resuspended at TFE 
/ 50mM ammonium bicarbonate 50% (v/v), reduced at 10mM DTT (30min, 56°C) and al-



















no-HPLC system (Eksigent Technologies nanoLC Ultra 1D plus, AB SCIEx) coupled online 
to a TripleTOF 5600 mass spectrometer (AB SCIEx) equipped with a nano-spray ioniza-
tion source (NanoSpray III, AB SCIEX) with a fused-silica nano spray tip (10µm x 120mm 
PicoTip emitter, New Objective). An analytical nano-Acquity UPLC column (1.7 µm, BEH 









initial conditions were restored to reequilibrate the column.
13.2.2. Data acquisition
The acquisition was performed in positive ionization mode using an IonSpray volt-
age Floating (ISvF) of 2800 v, curtain gas pressure (CUR) of 20 psi, interface heater tem-
perature (IHT) of 150°C, nebulizer ion source gas 1 pressure (GS1) of 30 psi, and decluster-
ing potential (DP) of 85 v. The data were acquired according to the information-dependent 
acquisition (IDA) mode, using the Analyst TF 1.5 (AB SCIEx) software. The acquisition 
cycles consisted of a 250ms MS survey scan within 350-1250 m/z range, followed by a max-
imum of 25 MS/MS scans of 100ms within 100-1500 m/z range. Only ions with a higher 
intensity greater than 90 counts and a charge between +2 and +5 were selected for further 
collision-induced dissociation (CID), whose collision energy (CE) was set as variable, de-







trix  Science) against a protein database without isoforms concatenated to the correspond-
ing decoy sequences using DBtoolkit (v4.1.4). The selected human and mouse databases, 
containing 40 470 and 33 604 entries, were released in January 2016 and July 2016 re-
spectively (UniProtKB/SwissProt database). Search parameters were set as follows: parent 
ion tolerance was 25 ppm and fragment ion mass tolerance was 0.05 Da. Carbamidomethyl 
cysteine was specified in Mascot as fixed modification, while oxidation of methionine and 
acetylation of the N-terminus were specified in Mascot as variable ones. Additionally, for 





the same conditions, and proteins were grouped using protein cluster analysis option. For 
statistical analysis, a  false discovery rate (FDR) ≤ 1% at  the protein  level was applied to 
filter false positives.
The quantitative analysis was performed by Proteobotics. The signals of the peptides 
with and without labeling were detected, eliminating the noise and correcting the propor-
tion between them. A fold change was calculated with the signal variations between pairs of 
peptides, while the proteins were filtered applying a FDR ≤1%.
13.3. Bioinformatic analysis
To classify proteins according to their location within the cell, the information con-
tained in the cellular component ontology of GeneOntology has been used. Access to this 
information for each protein from the UniProt database and the clustering of the analyzed 
proteins in different categories was facilitated by the Protein Information and Knowledge 
Extractor (PIKE) application (Medina-Aunon et al., 2010). Twelve categories were created 
to cover the main cell locations, with special interest in plasma membrane and cell surface 
for this study (Table 3).
For the functional analysis of proteins, EnrichmentMap, a plug-in of Cytoscape (ver-
sion 3.2.1) was used. Proteins were grouped in Gene Ontology categories, where node size 




protein overlap between Gene Ontology categories. For the venn diagrams, Biovinci (ver-
sion 1.1.3) was used.
13.4. Statistical analysis
The data were analyzed with the GraphPad Prism program, applying the one- or two-
way ANOvA for multiple comparisons. Three replicates were performed in these experi-
ments.
Table 3: Cluster names and their corresponding cellular 
component GO terms

















1. Analysis of different methodologies for the study of T cell 
membrane proteome
To obtain a T cell surfaceome map as complete as possible, we employed two ap-
proaches to enrich cell surface proteins: biotin labeling and subcellular fractionations. 
From these cell surface protein enriched samples we performed shotgun proteomic analy-
sis by mass spectrometry technology (LC-MS/MS) with the objective of identifying most of 
the membrane proteins we could. The optimization of these methodologies was carried out 
in Jurkat T cells, since this is a T cell line model for T-cell receptor signaling study (Abra-
ham & Weiss, 2004).
1.1. Enrichment of membrane proteins by biotinylation
We first performed an enrichment of cell surface proteins using biotin labeling. This 
enrichment step coupled to mass spectrometry has been used previously (Peirce et al., 
2004). This strategy consists of labeling primary amines of proteins in the outer face of the 




We initially performed a titration in Jurkat T cells in order to estimate the optimal 
concentration of biotin to recover most membrane proteins as possible with minimal la-
beling (Figure 6). We chose different concentrations, and after carrying out the biotinyla-
tion and purification steps we verified protein labeling efficiency by western blot.First, we 
checked by HRP-conjugated streptavidin that proteins of pull-down were labeled with bi-
otin. The higher the concentration of biotin employed, the greater the degree of labeling. 
Most biotin labeled proteins were detected in the bead-enriched fraction and not in the 
unbound fraction, suggesting that the stoichiometry of beads employed was correct and we 
could capture most of the biotinylated proteins (Figure 6A).
At  the  same  time, we measured  specific  subcellular  localization markers  to  evalu-
ate the degree of enrichment of membrane proteins compared to known cytosolic markers 
(Figure 6B). The presence of transferrin receptor in the bead-bound fraction indicated en-
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richment of transmembrane protein, whereas in the case of other markers such as GM130 
(Golgi),  pPKCα  (cytosol)  or  actin  (cytoskeleton)  no  apparent  protein was  detected.  The 
presence of PLCγ suggested that some protein-protein interactions could be preserved and 
non-transmembrane proteins with clear membrane localization could also be enriched in 
these biotin-pull-down fractions, resulting in enrichment in proteins temporally associat-
ed to membrane. Nonetheless, for subsequent experiments we chose the concentration of 
1mg/mL of biotin, as this allowed more robust labeling without increasing contamination 
of other non-plasma membrane proteins.
Next we took advantage of this technology to see the effect of DAG metabolism on 
the cell surfaceome. We mimicked DGK loss or T cell activation by addition of the DAG 
analogue PMA, a phorbol ester that is frequently used to examine the effects of sustained 
DAG generation. This molecule simulates effects of shedding and changes the expression 
of membrane proteins (Ahram et al., 2005; Gharbi et al., 2013). We validated again by 
western blot the efficiency of biotinylation and the effect of PMA addition (Figure 7). Our 




































Figure 6: Biotin titration
Titration of the optimum concentration of biotin for correct labeling and pre-
cipitation of plasma membrane proteins. (A) The expression of different pro-
teins which act as subcellular localization markers was checked in biotinylated 
proteins pull-down and in the total cell lysate by western blot. (B) The reco-





total lysate were monitored to check for correct PMA activity (Ahnadi et al., 2000). Analysis 
of the pull-down showed a lower level of transferrin receptor in the PMA treated samples. 
This would be in agreement with internalization of the receptor in response to PMA treat-
ment (Klausner et al., 1984; Meng et al., 2010).
1.2. Shotgun proteomic analysis 
Once we obtained a pull-down of enriched cell surface proteins by biotinylation, a 
shotgun proteomic analysis was performed. We did two replicates of Jurkat cell line that 
were analyzed together. In each replicate cells were treated with PMA or vehicle (DMSO). 
A control sample from Jurkat cells that were not treated with biotin was used in order to 
distinguish non-specific contaminant proteins that can interact with streptavidin beads.
The number of proteins identified by mass spectrometry was similar in PMA or in 
DMSO treated cells (Figure 8) (Supplemental table 1). Furthermore, the proteins identified 
in the different biological replicates was reproducible, with 65% of the proteins identified 

















Figure 7: Cell surface protein enrichment in Jurkat T cells by biotinylation
A Jurkat T cell culture was treated with PMA for 4h. After this time period an 
enrichment of plasma membrane proteins was carried out by biotinylation. 




























































































Control -PMA +PMA Total
Replicate 1
Replicate 2
Figure 8: Shotgun analysis of Jurkat T cell surface proteins.
After performing treatments with PMA and the enrichment biotin process, 
we identified the proteins by mass spectrometry. (A, B) Almost 3000 proteins 
were detected in total by combining two replicates. (C, D) and about 2000 
proteins after subtracting non-specific binding proteins identified in control. 
(E, F) Most of these proteins were shared between both treatments. This be-
havior was observed in both replicates as well as in the sum of both, although 
in the second replicate fewer proteins were identified. The proteins identified 
in each treatment were compared to check the reproducibility between repli-







exclusively to one of the two treatments. This data suggest that PMA treatment has minimal 
impact on global cell surfaceome, in we consider all the proteins identified.
1.3. GO representation of proteomic results 
To corroborate the efficiency of enrichment of cell surface proteins following protein 
biotinylation, we analyzed the ontology annotations of the proteins identified and focused 
on their described cellular component category and predicted subcellular localization. For 
this purpose we used the protein annotations stored in the ontology of “cellular component” 
of Gene Ontology project (Ashburner et al., 2000). This tool permits to check whether a 
protein belongs to Gene Ontology categories related to plasma membrane and cell surface. 
Complete Total Common -+PMA -PMA +PMA
NUCLEAR 2337 54% 941 44% 863 44% 54 42% 24 44%
CYTOPLASM 2365 54% 923 43% 837 43% 50 38% 36 65%
PLASMA MEMBRANE 922 21% 668 31% 613 32% 41 32% 14 25%
CELL SURFACE 148 3% 81 4% 74 4% 6 5% 1 2%
PERINUCLEAR 407 9% 161 8% 145 7% 10 8% 6 11%
GOLGI COMPLEX 250 6% 154 7% 144 7% 6 5% 4 7%
ENDOPLASMIC RETICULUM 383 9% 306 14% 277 14% 24 18% 5 9%
ENDOSOME 181 4% 97 5% 88 5% 6 5% 3 5%
MITOCHONDRIAL 741 17% 450 21% 422 22% 20 15% 7 13%
PEROXISOME 61 1% 51 2% 46 2% 2 2% 3 5%
CYTOSKELETON 355 8% 123 6% 112 6% 6 5% 5 9%
EXTRACELLULAR 1098 25% 504 24% 465 24% 29 22% 10 18%
4359 2126 1941 130 55
Figure 9: Subcellular protein distribution according to GO terms.
After shotgun analysis we studied the subcellular localization using anno-
tations of cellular component from Gene Ontology. Unlike Jurkat complete 
cell lysate obtained with a commercial kit, a slight increase in the number of 
plasma membrane proteins was seen in enriched fractions by biotinylation. 
This represented a percentage above 30%. Furthermore, percentages of other 
contaminants fractions as nucleus or cytoplasm suffered consequent decrea-
ses. For proteins found only in one of the two PMA treatments, the percenta-
ge of membrane proteins was slightly lower.
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By bioinformatic application PIKE (Medina-Aunon et al., 2010) it is possible to obtain the 
GO codes of these proteins automatically. The application uses this information to cluster 
proteins according to subcellular localization.
Our results showed an increased number of plasma membrane proteins if we com-




was  reduced  from 922  to 668. This  effect was accompanied with a decrease  in proteins 
identified from other subcellular localizations such as nucleus and cytosol. We could also 
detect an increase in internal organelles, for instance in endoplasmic reticulum and mito-
chondria.
If we analyze jointly the protein content of plasma membrane in the treatments with 
PMA addition and without it, there were some differences. In the case of proteins shared in 
both treatments, the results were similar to the total. For these proteins present exclusively 
in one of the two treatments, the percentages of plasma membrane proteins were lower, 
and there were also decreases in other categories. Must be taken into account that in these 
cases the number of proteins was considerably lower and this may interfere with the distri-
bution of percentages.






















Figure 10: Plasma membrane, cell surface and cytosol clusters overlap.
Once the clustering according to the subcellular localization of proteins was 
performed, we analyzed the overlap among the categories of plasma mem-
brane, cytosol and cell surface. We compared cases of proteins from total cell 
lysate (A) and those obtained by biotinylation (B). Whereas the number of 
proteins of the three clusters was higher in the first case, in biotinylation the 
exclusive plasma membrane proteins reached a similar number in absolute 
























locations. To evaluate this, we analyzed the possible overlap between plasma membrane, 
cytosol and cell surface, comparing total cell lysate proteins and those enriched by bioti-
nylation (Figure 10). The number of proteins is higher in all cases in the total lysate. How-
ever in the case of plasma membrane unique proteins the number was similar although the 
percentage was greater than in the case of proteins enriched by biotinylation.
1.4. High salt wash biotinylation
In an attempt to improve the percentage of enriched cell surface proteins, we mod-
ified biotinylation conditions to avoid contamination by non-specific protein binding. We 
increased the number of washes after the binding of the proteins to the neutravidin, as well 
as the salts concentration of the wash buffer to increase the ionic strength. We performed 













Control -PMA +PMA Total
Figure 11: Shotgun and subcellular distribution analysis of biotinylation 
with high-salt wash method.
We performed a biotinylation with modified conditions to optimize plasma 
membrane proteins enrichment. (A) About 3000 proteins were identified 
combining both treatments. (B) After substracting proteins detected in con-
trol, the total number was about 2800. (C) Proteins shared by both treatments 


















































analyzing the subcellular localization results by Gene Ontology, we did not see changes in 
the percentages of the proteins of the plasma membrane and of the cell surface. We con-
cluded that no improvement was obtained following harsher purification conditions.
1.5. Optimization of biotinylation by using sulfo-NHS-SS-biotin
In order to improve the yield of biotinylation to obtain a greater number of cell sur-
face proteins, we compared the performance of the biotin used in the previous work to a 
modified biotin reagent  incorporating an internal disulfide bridge (Figure 12). This mol-
ecule, being more soluble, helps to avoid intracellular penetration, and also allows elim-
ination of  the biotin tag after  labeling (Peirce et al., 2004). After comparing the efficacy 
of both reagents, we observed that in both cases the labeling of proteins with biotin was 
limited to the plasma membrane, so that contamination by labeling of internal proteins is 
low in any case. In spite of this, the recovery of membrane proteins such as the transferrin 
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Figure 12: Comparison and titration of sulfo-NHS-biotin and sulfo-NHS-SS-
biotin in Jurkat T cells.
(A) Western blot showing the expression of subcellular localization markers. 
Equimolar amounts of biotin were used for the titration of the biotin reagents, 
so the concentrations are referred to mg/mL sulfo-NHS-biotin in both cases. 
In the case of the transferrin receptor there was a higher yield with sulfo-NHS-
SS-biotin. (B) Immunofluorescence in which the biotin of labeled proteins was 
detected to analyze its subcellular localization. In both cases the labeling was 













































as a strategy to eliminate the biotin tag after the pull-down with neutravidin. Thus during 
the shotgun proteomic analysis the possibility of problems in the detection of biotinylated 
peptides was overcome. To optimize the procedure, we tested several elution conditions, 
verifying the presence of proteins in the pulldown by means of western blot (Figure 13). The 
largest recovery of proteins was observed when the biotinylated proteins bound to beads 
with neutravidin were boiled under reducing conditions. If only boiling or reducing condi-
tions were applied, protein production was lower, which can be observed in the case of the 
membrane protein transferrin receptor.
1.6. Enrichment of membrane proteins by subcellular fractionation
Performance enrichment using biotin based purification approaches were similar to 
those obtained in other studies (Weekes et al., 2010). We attempted alternative techniques 
to improve the percentage of plasma membrane proteins. As a new approach in our study 
we used a commercial subcellular fractionation kit to obtain cytosol, membranes and nu-
cleus fractions. Thus, in addition to our membrane enriched fraction we can analyze the 
other fractions to search proteins from other locations.
For a first fractionation performance evaluation, we carried out a western blot from 
total lysates of the three fractions (Figure 14). We checked the expression of proteins that 
are normally found in a particular location in the cell, so they can serve as subcellular mark-
Figure 13: Evaluation of the 
elution of biotinylated pro-
teins by sulfo-NHS-SS-biotin.
The western blot showed that 
the treatment with larger pro-
tein recovery in the pull-down 
was boiling under reducing 
conditions. This recovery was 
greater than in the elution 
with only a reducing agent, or 
simply boiling. The integrity of 
sulfo-NHS-SS-biotin was main-
tained if these conditions were 
















1.Boiling 15’ with sample buffer
2.DTT o/n
3.Boiling 15’ with no β-mercaptoethanol
4.Sample buffer with no β-mercaptoethanol
Results
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ers. For plasma membrane proteins we chose the transferrin receptor as reference, and 
Golgi protein GM130 for inner membranes. The blot showed how these proteins were de-
tected preferably in the membrane fraction. In the cytosol fraction we observed a clear ex-
pression of tubulin, while the nucleus fraction included histones. In general, contamination 
between fractions was reduced.
Shotgun proteomic analysis
The next step was to perform a shotgun proteomic analysis of the distinct fractions 
from cell lysates. This permitted us to identify the proteins present in each fraction, and 
actually evaluate the efficiency of the fractionating method. In our attempt to report the 
highest number of plasma membrane proteins, we used two different separation methods 
prior to the analysis by mass spectrometry. These were a protein separation by molecular 
mass by a one-dimensional SDS-PAGE gel, and a separation by hydrophobicity by reverse 
phase HPLC chromatography in basic pH. We wanted to check if the method used to reduce 
protein complexity can affect the number of plasma membrane proteins.
The proteomic analysis using the two separation methods indicated that in both cas-
es a similar protein number was reached both for total and for each fraction (Figure 15) 
(Supplemental table 4A and B). However there was a slight advantage in the separation by 
RP-HPLC in basic pH. We detected near 6000 proteins, 4000 in cytosol and nucleus frac-
tions, and almost 5000 in membrane fraction. The overlap between fractions was similar 
to biotinylation replicates. Within each experiment there was a significant overlap between 
cytosol, membrane and nucleus, so despite the results obtained by western blot there was 
contamination among fractions.
Figure 14: Subcellular fractionation 
from Jurkat T cells.
From a Jurkat T cell culture we carried 
out a subcellular fractionation using a 
commercial kit. To check the fractio-
nation effectiveness we performed a 
western blot with cell lysates of the 
resulting fractions. It showed how the 
membrane fraction predominantly 
contained plasma membrane (trans-
ferrin receptor, TfR) and inner mem-
brane proteins (GM130). Tubulin and 

























Cytosol Membrane Nucleus Total
SDS-PAGE
RP-HPLC
Figure 15: Results of Jurkat T cell fractionation shotgun analysis.
After making the subcellular fractionation, we analyzed by mass spectrometry 
the three fractions obtained. Previously we performed a separation to reduce 
the complexity of the sample by monodimensional SDS-PAGE or RP-HPLC in 
basic pH. (A) The amount of proteins detected in total and in each fraction 
was very similar with both methods. (B) Reproducibility was around 65% in 
cytosol (top), membranes (middle) and nucleus (bottom) fractions. (C) The 
analysis of the overlap between the three fractions of SDS-PAGE (top) and RP-
HPLC (bottom) showed that proteins common to the three fractions were the 











































































FRACTIONATION GEL Total Fract. Cytosol Fract. Membrane Fract. Nucleus
NUCLEAR 2819 50% 2025 55% 2224 47% 2224 57%
CYTOPLASM 2900 52% 2410 66% 2415 52% 1969 50%
PLASMA MEMBRANE 1363 24% 701 19% 1269 27% 866 22%
CELL SURFACE 209 4% 143 4% 199 4% 138 4%
PERINUCLEAR 502 9% 416 11% 438 9% 361 9%
GOLGI COMPLEX 352 6% 220 6% 320 7% 221 6%
ENDOPLASMIC RETICULUM 532 10% 205 6% 521 11% 359 9%
ENDOSOME 237 4% 168 5% 228 5% 148 4%
MITOCHONDRIAL 844 15% 358 10% 799 17% 630 16%
PEROXISOME 74 1% 26 1% 74 2% 53 1%
CYTOSKELETON 463 8% 397 11% 393 8% 345 9%
EXTRACELLULAR 1272 23% 959 26% 1184 25% 902 23%
5594 3675 4684 3902
Figure 16: Fractionation subcellular protein distribution according to GO 
terms.
By both protein separation methods, SDS-PAGE (A and C) and RP-HPLC (B and 
D) we obtained similar results. In the case of the membrane fraction there 
was a slight enrichment in plasma membrane proteins and inner membranes, 
which however did not achieve the enrichment obtained by biotinylation. In 
cytosol and nucleus fractions there was also enrichment in these categories.
FRACTIONATION RP-HPLC Total Fract. Cytosol Fract. Membrane Fract. Nucleus
NUCLEAR 2927 50% 1931 55% 2338 49% 2125 56%
CYTOPLASM 3018 51% 2333 67% 2400 50% 1826 48%
PLASMA MEMBRANE 1411 24% 597 17% 1255 26% 845 22%
CELL SURFACE 227 4% 125 4% 204 4% 133 4%
PERINUCLEAR 514 9% 385 11% 431 9% 330 9%
GOLGI COMPLEX 355 6% 201 6% 310 6% 200 5%
ENDOPLASMIC RETICULUM 542 9% 181 5% 506 11% 361 10%
ENDOSOME 248 4% 180 5% 224 5% 147 4%
MITOCHONDRIAL 977 17% 325 9% 919 19% 683 18%
PEROXISOME 80 1% 28 1% 78 2% 54 1%
CYTOSKELETON 456 8% 341 10% 364 8% 297 8%
EXTRACELLULAR 1374 23% 977 28% 1242 26% 877 23%



























































1.7. GO representation of proteomic results
The analysis by the Gene Ontology terms in each fraction confirmed enrichment in 
cytosol, plasma membrane and nucleus proteins with respect to total cell lysates (Figure 
16). Enrichments nonetheless were moderate, especially in the case of membrane fraction 
where the enrichment was lower than that achieved by biotinylation. In this fraction there 
was also some enrichment in inner membranes. Only slight differences between the two 
separation methods prior proteomic analysis were observed. They were lower compared 
with the results of biotinylation enrichments.
To analyze the performance of the fractionation protocol to isolate cell surface pro-
teins, we studied the presence of cluster of differentiation proteins or CD, cell surface pro-
teins used to characterize the cell type by monoclonal antibodies (Bernard & Boumsell, 
1984). In fractionation after gel separation all CD antigens were comprehended in mem-
brane fraction, although some of them can be shared in the other fractions (Figure 17). 
Same situation was observed in fractionation carried out after RP-HPLC separation, except 
for one protein uniquely detected in cytosol fraction. This indicates that most characteristic 
cell surface proteins in immune cells were enriched in membrane fraction.
1.8. Summary of membrane proteins recovery 
After analyzing  the results of  the different enrichment  techniques, we represented 
all the data together to determine the optimal approach we would use in the following ex-
periments (Figure 18). When comparing the number of total proteins, this was smaller in 















Figure 17: CD antigens distribution in fractions from Jurkat fractionations.
CD antigens were mostly detected in membrane fractions in SDS-PAGE (A) and 
RP-HPLC (B) fractionations. Some of them were part of cytosol and nucleus 
fractions, but shared with membrane. Only one protein in HPLC-RP fractiona-




















of membrane proteins and cell surface. However the largest increase in the percentage of 
plasma membrane proteins occurred in the biotinylation approach. The cell surface per-
centage of protein remained equal in all cases, but not when analyzing the proteins clas-
sified as clusters of differentiation. In biotinylation and fractionation we reached a larger 
number of CD proteins than in the total cell lysate. For biotinylation the number was even 
greater if we consider CD antigens that were discarded because of they were also detected 
in the control treatment.
FRACTIONATION GEL Complete Jurkat biotinylation Jurkat fractionation (Mem) Gel
Jurkat fractionation 
(Mem) RP
NUCLEAR 4362 2126 4684 4801
CYTOPLASM 922 21% 668 31% 1269 27% 1255 26%
PLASMA MEMBRANE 148 3% 81 4% 199 4% 204 4%
CELL SURFACE 34 39 62 56
Figure 18: Summary report of plasma membrane proteins enrichment.
(A) In this table the amount of proteins of each enrichment approach was 
shown, and the percentage of Gene Ontology categories plasma membrane 
and cell surface proteins. The number of CD antigens is included too. (B) Gra-
phs below represent the overlap in cell surface (top) and plasma membrane 
(bottom) proteins between biotinylation enrichment and membrane frac-









































We also compared the overlap between cell surface and plasma membrane GO clus-
ters of Jurkat biotinylation enrichment and Jurkat fractionations. We expected more sim-
ilarity in cell surface than in plasma membrane proteins, because biotinylation is theoreti-
cally more specific for cell surface proteins, while fractionation recovers all the membrane. 
However the coincidence is small, and even smaller in cell surface proteins.
2. Analysis of mouse T cell surfaceome
After optimizing cell surface protein enrichment techniques in the Jurkat T cell line, 
we moved  to  a mouse model where we  could  study  the  effects  in  a  specific  case of  sur-
faceome changes. For this we focused on the OT-I model of CD8 T cells that allows the 
differentiation to cytotoxic T cells. OT-I mice express a TCR with the transgenic α (Vα2) 
and β (Vβ5) chains, capable of recognizing an ovalbumin peptide in the context of MHC 
class I H2-Kb (Hogquist et al., 1994). This model allows us to purify peripheral naïve CD8 
T cells from the spleen or lymph nodes, activate them in culture with the agonist peptide, 
and expand them with several rounds of IL-2 to obtain a large number of CTL cells to per-
form shotgun proteomic studies. These mice were also crossed with DGKζ-deficient strain 
(Zhong et al., 2003), which allows us to analyze CTL with this phenotype.
2.1. Study of PMA on splenocytes
Prior to the study of mouse CTL, a relatively homogeneous population, we checked 
the expression of membrane proteins by biotinylation in activated splenocytes obtained 
from WT mice. These cells were extracted from spleen and stimulated with concanavalin 
A for 48h. After short treatment with PMA or control, we performed enrichment of cell 













Figure 19: Shotgun analysis of splenocytes.
A) Number of proteins detected in each treatment and in total. B) Overlap 
between treatments with and without PMA. About 70% of the proteins were 
detected in both treatments. Most of the remaining proteins were detected 














proteomics (Figure 19) (Supplemental table 5). We made only one replicate, so we obtained 
less total proteins than in the CTL experiment. Most proteins were detected both in the ab-
sence or presence of phorbol ester. Among those not common to both treatments, there was 
a greater expression of proteins in the treatment with PMA, probably because there were 
already more proteins in this treatment previously.
We also analyzed the protein distribution according to GO terms (Figure 20). With 
respect to CTL data there was an increase in cell surface proteins, and plasma membrane, 
although  in general  the number of proteins was similar. There was also a significant  in-
crease in extracellular proteins. The cell heterogeneity can be checked by analyzing the lists 
of proteins detected, which include B cell, CD4 T and CD8 markers among others.
Total Common -+PMA -PMA +PMA
NUCLEAR 581 45% 419 47% 35 33% 127 42%
CYTOPLASM 564 43% 396 44% 44 42% 125 42%
PLASMA MEMBRANE 420 32% 288 32% 29 28% 103 34%
CELL SURFACE 107 8% 76 9% 11 10% 20 7%
PERINUCLEAR 116 9% 84 9% 9 9% 23 8%
GOLGI COMPLEX 83 6% 62 7% 5 5% 16 5%
ENDOPLASMIC RETICULUM 192 15% 145 16% 16 15% 31 10%
ENDOSOME 55 4% 32 4% 5 5% 18 6%
MITOCHONDRIAL 301 23% 228 26% 25 24% 48 16%
PEROXISOME 27 2% 20 2% 5 5% 2 1%
CYTOSKELETON 93 7% 58 6% 4 4% 31 10%
EXTRACELLULAR 537 41% 418 47% 30 29% 104 35%
1298 893 105 300
Figure 20: Subcellular protein distribution of mouse splenocytes according 
to GO terms.
The percentages of plasma membrane and cell surface proteins were slightly 
higher than in the CTL experiment. There was also a higher proportion of pro-
teins classified as “extracellular”.
45% 47%
33%























2.2. Enrichment of membrane proteins by biotinylation in mouse CTL
 Next we differentiated CTL WT or deficient in DGKζ and used a biotinylation proto-
col to enrich CTL lysates in cell surface proteins (Figure 21). After extracting lymph node 
cells from OT-I mice, we stimulated with OvA and expanded with IL-2. Then we re-stim-
ulated with PMA, labeled with biotin, lysed, and performed a pull down with neutravidin. 
We analyzed by western blot the effect of activation with PMA and the subcellular local-
ization markers that appeared in the pulldown. We observed that when PMA was added, 
ERK activation occurred in both WT and DGKζ-/- mice, with higher basal ERK activation in 
DGKζ-/- mice. Analysis of the pull down confirmed enrichment of transferrin receptor, that 
again was lost upon PMA treatment with stronger effect on DGKζ-/-.
2.3. Study of PMA on CTL: shotgun proteomic analysis
Following the same procedure that was used in Jurkat T cells, we performed a bioti-
nylation experiment on CTL treated with or without PMA to enrich cell surface proteins, 
and subsequently analyzed by shotgun proteomics (Figure 22) (Supplemental table 6). The 
results showed a similar number of proteins between treatments with and without PMA, 











Figure 21: Cell surface protein enrichment by biotinylation in mouse CTL.
(A) Scheme depicting the procedure used to obtain CTL from lymph nodes of 
OT-I mice. (B) Western blot showing the activation of CTL with PMA and sub-
cellular localization markers. In the pull down there was an enrichment in the 
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2.4. Study of PMA on CTL: GO representation of proteomic results
Then we analyzed the distribution of the subcellular localization of the detected pro-
teins by proteomics using the GO categories (Figure 23). Our results showed a proportion 












Control -PMA +PMA Total
CTL Biotin
Figure 22: Results of shotgun analysis of mouse CTL.
(A) Total numbers of proteins per treatment, combining the two replicates. 
(B) Representation of the two replicates, the same control was used for both. 
(C) Treatments with the differentiated replicates, once the control proteins 
were subtracted. (D) Reproducibility between replicates. (E) Treatments wi-
thout control proteins including both replicates. (F) Overlap between treat-














































































teins for both treatments and proteins that were only detected in the absence or presence 
of PMA. These differences could be explained by alterations due to the small number of 
proteins in these cases. We also expected some overlap between GO categories.
2.5. PMA effect in CD proteins expression from mouse CTL
As we already did in experiments with Jurkat T cells, we checked the expression of 
proteins  classified as  cluster of differentiation,  to  evaluate  the  efficiency  in  the  recovery 
of these surface molecules (Figure 24). We also obtained a snapshot of the expression of 
markers in membrane, to evaluate PMA-inducing changes. We could verify that the vast 
majority of markers were common in both replicates, including the expected CD8a and b, 
components of the TCR, costimulatory molecules like CD28 and activation markers like 
Total Common -+PMA -PMA +PMA
NUCLEAR 1177 48% 1064 48% 14 47% 99 50%
CYTOPLASM 1098 45% 988 45% 18 60% 92 46%
PLASMA MEMBRANE 691 28% 632 29% 10 33% 49 25%
CELL SURFACE 145 6% 140 6% 1 3% 4 2%
PERINUCLEAR 208 9% 180 8% 6 20% 22 11%
GOLGI COMPLEX 150 6% 131 6% 2 7% 17 9%
ENDOPLASMIC RETICULUM 240 10% 226 10% 4 13% 10 5%
ENDOSOME 102 4% 92 4% 1 3% 9 5%
MITOCHONDRIAL 394 16% 349 16% 3 10% 42 21%
PEROXISOME 37 2% 32 1% 1 3% 4 2%
CYTOSKELETON 187 8% 165 8% 3 10% 19 10%
EXTRACELLULAR 559 23% 521 24% 7 23% 31 16%
2429 2200 30 199
Figure 23: Subcellular protein distribution of mouse CTL according to GO 
terms.
The number of proteins and percentages associated with the main categories 
of GO of cellular component are represented. The percentages were similar 
to those obtained for Jurkat T cells. They also remained among proteins com-
mon in both treatments and those that were only detected in one of them.

























CD44, CD69 or CD25. PMA dependent changes were not reproducible between the two 
replicates except for CD120b (TNFR2) that was found only in non-PMA treated samples. 
Changes in the replicates nonetheless identified TNF family of ligands or receptors as well 
as inhibitory checkpoints.
 Study of CTL from DGKζ-deficient mice by biotinylation
In previous experiments we attempted to characterize changes in the CTL surfaceome 
in acute changes in DAG abundance, through the model of phorbol ester addition. These 
are rapid changes that may be due to phenomena such as the endocytosis/degradation of 
membrane proteins or shedding processes. The next step was to analyze changes in the 
CTL surfaceome from mice deficient in DGKζ, in which this deficit in DAG metabolism is 
sustained over time and may affect CTL differentiation. To this end, we used biotinylation 
to enrich cell surface proteins and proteomics to detect the expression of as many proteins 
as possible.
After following the same process to obtain differentiated CTL, we labeled with biotin, 
lysed and enriched through pull down with neutravidin. We analyzed the proteins present 
in the extract through shotgun proteomics (Figure 25) (Supplemental table 7). We detect-
ed in this case a greater amount of proteins in WT cells than in DGKζ deficient cells. This 
explains that the overlap between both treatments was less than other times, around 50%. 
Regarding the distribution of proteins according to the categories of GO, the percentage of 














































































































































































Replicate 2 -PMA, +PMA
Only -PMA
Only +PMA
Figure 24: Identified CD proteins in mouse CTL biotinylation.
Drawing showing the expression in both replicates of the CD proteins. Orange 
indicates expression both in the presence and absence of PMA. In red are re-
presented the proteins that would disappear when adding PMA, and in green 
those that would be expressed.
Results
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Total Common WT DGKζ-/- Only WT Only DGKζ-/-
NUCLEAR 705 43% 368 46% 284 39% 53 43%
CYTOPLASM 794 48% 423 53% 295 41% 76 62%
PLASMA MEMBRANE 547 33% 274 34% 238 33% 35 28%
CELL SURFACE 139 8% 84 10% 48 7% 7 6%
PERINUCLEAR 150 9% 79 10% 52 7% 19 15%
GOLGI COMPLEX 113 7% 54 7% 49 7% 10 8%
ENDOPLASMIC RETICULUM 237 14% 107 13% 121 17% 9 7%
ENDOSOME 84 5% 38 5% 41 6% 5 4%
MITOCHONDRIAL 409 25% 188 23% 214 30% 7 6%
PEROXISOME 34 2% 9 1% 24 3% 1 1%
CYTOSKELETON 118 7% 60 7% 41 6% 17 14%
EXTRACELLULAR 689 42% 398 49% 262 36% 29 24%
1648 805 720 123
Figure 25: Shotgun analysis and subcellular protein distribution according to 
GO terms of mouse deficient in DGKζ
(A) Number of proteins detected in WT and DGKζ-/-cells, as well as in total. (B) 
Overlap between the two cell types. (C) The distribution according to GO is 
shown below, in which the values of plasma membrane and cell surface were 
higher than in previous experiments.



















































in extracellular proteins can be observed.
 Study of CTL from DGKζ-deficient mice by fractionation
 To complete the biotinylation study we performed two fractionations comparing the 


















Cytosol Membrane Nucleus Total
WT
DGKζ-/-
Figure 26: Shotgun analysis of fractionation of mouse deficient in DGKζ.
(A) Number of proteins in total and in each fraction for WT and DGKζ-/- condi-
tions. (B) Overlap of the three fractions between the two conditions, in cyto-
sol (top), membranes (middle) and nucleus (bottom) fractions. (C) Overlap 












































































tionation according to the instructions recommended by the manufacturer. We reserved 
a quantity of lysate from each fraction for proteomic analysis (Figure 26) (Supplemental 
FRACTIONATION WT Total Fract. Cytosol Fract. Membrane Fract. Nucleus
NUCLEAR 1571 49% 935 52% 992 43% 1305 55%
CYTOPLASM 1577 49% 1172 65% 1103 48% 1204 51%
PLASMA MEMBRANE 785 24% 370 20% 665 29% 514 22%
CELL SURFACE 158 5% 90 5% 138 6% 114 5%
PERINUCLEAR 288 9% 192 11% 214 9% 232 10%
GOLGI COMPLEX 199 6% 104 6% 163 7% 137 6%
ENDOPLASMIC RETICULUM 306 10% 106 6% 283 12% 201 8%
ENDOSOME 148 5% 95 5% 131 6% 94 4%
MITOCHONDRIAL 637 20% 227 13% 568 25% 411 17%
PEROXISOME 47 1% 20 1% 44 2% 31 1%
CYTOSKELETON 233 7% 164 9% 156 7% 190 8%
EXTRACELLULAR 1020 32% 766 42% 892 39% 806 34%
3208 1814 2312 2375
Figure 27: Subcellular protein distribution of WT and DGKζ-/- CTL fraction-
ations according to GO terms.
(A and C) GO distribution of WT fractionation. (B and D) GO distribution of 
DGKζ-/- fractionation. In both cases the percentages were more similar to tho-
se obtained in Jurkat T cells, and were practically identical among them.
FRACTIONATION DGKζ-/- Total Fract. Cytosol Fract. Membrane Fract. Nucleus
NUCLEAR 1686 49% 1101 54% 1005 44% 1213 54%
CYTOPLASM 1666 49% 1291 63% 1093 47% 971 43%
PLASMA MEMBRANE 823 24% 375 18% 675 29% 544 24%
CELL SURFACE 163 5% 93 5% 144 6% 121 5%
PERINUCLEAR 311 9% 223 11% 217 9% 208 9%
GOLGI COMPLEX 211 6% 119 6% 161 7% 136 6%
ENDOPLASMIC RETICULUM 330 10% 117 6% 301 13% 235 10%
ENDOSOME 154 5% 108 5% 123 5% 89 4%
MITOCHONDRIAL 665 19% 229 11% 598 26% 465 21%
PEROXISOME 48 1% 16 1% 45 2% 30 1%
CYTOSKELETON 249 7% 179 9% 147 6% 189 8%
EXTRACELLULAR 1036 30% 778 38% 877 38% 647 29%



























































table 8). After the analysis we obtained more than 3000 proteins in total for each condi-
tion. In the case of the fraction of membranes we obtained more than 2000. If we compare 
between WT and DGKζ-/- for each fraction we found that the common proteins were mostly 
about 70%. Within each fractionation there was in turn a large overlap between fractions.
The distribution of GO terms was similar to that obtained during optimization with 
Jurkat T cells (Figure 27). The plasma membrane percentages in the membrane fraction 
were around 30%, while the cell surface fraction was 6%. More proteins were obtained in 
total, but the proportion of membrane proteins was lower.
We also verified the presence of CD antigens  in WT and DGKζ-/- fractionations, as 
we did in Jurkat T cell (Figure 28). The membrane fraction collected again the majority of 
these proteins, although much of these were not exclusive, but overlap with other fractions.
2.6. Summary of membrane proteins recovery in mouse cells
As we did when analyzing efficiency in Jurkat T cells, we collected in a table the re-
sults obtained from membrane proteins by fractionation and biotinylation in the different 
experiments with mouse cells (Table 4). The number of total proteins obtained was lower 
than in the case of Jurkat T cells. However in the case of biotinylation there was a similar 
number of membrane proteins, and higher of cell surface. The percentages of membrane 
and cell surface proteins were also higher in mouse, as well as the number of CD antigens. 
In the case of fractionation the total numbers were higher due to the large number of pro-















Figure 28: CD antigens overlapping in WT and DGKζ-/- fractionations.
Diagram depicting CD antigen overlap between different fractions, in WT (A) 

















2.7. Expression of CD antigens in WT and DGKζ-/- CTL
We  have  previously  studied  the  effect  on  rapid  changes  in  DAG  concentrations 
through  the PMA addition model, without observing  large differences  in  the  expression 
of cell surface proteins. We next showed the expression of CD antigens obtained by prior 
enrichment by biotinylation or fractionation. In general a smaller number of them was 
detected, although the most characteristic CTL proteins are maintained. We detected some 
new proteins that we did not detect. There are divergences between both techniques, but 
comparing all the experiments we achieve a CD antigen expression profile that can give us 
an idea of the WT and DGKζ deficient CTL phenotypes (Figure 29).
Table 4: Summary report of plasma membrane proteins enrichment in mouse T cells. This table 
summarizes the number and percentages of proteins obtained in all the mouse experiments. The 
numbers of CD antigens in parentheses represent the total number of these proteins, rescuing 
those of the control treatment.
FRACTIONATION GEL Complete Jurkat biotinylation Jurkat fractionation (membrane) Gel
Jurkat fractionation 
(membrane) RP
NUCLEAR 4362 2126 4684 4801
CYTOPLASM 922 21% 668 31% 1269 27% 1255 26%
PLASMA MEMBRANE 148 3% 81 4% 199 4% 204 4%


























































































































































































































Figure 29: Identified CD antigens in mouse CTL WT and DGKζ-/-.
The graphic depicts the CD antigen expression pattern in WT and DGKζ-/- cells. 
Orange indicates expression both in WT and DGKζ-/-. Proteins detected only in 
WT and DGKζ-/- cells are represented in green and red, respectively.
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2.8. Analysis of protein expression by flow cytometry




mouse strains. However, when proteomic analysis shows presence/absence of proteins, it 




in differentiated CTL from OT-I mice in both WT and DGKζ-/-. In addition, their expression 
was evaluated in DGKα-/- mice, which lack this other DGK isoform.
The results show that the expression profiles of the CD28, CD80 and PD-L1 proteins 
are very  similar  in both DGKζ-/-  and DGKα-/- mice (Figure 30). The differences are very 
low both intra and interexperimentally, and when analyzing the differences in fluorescence 
emission statistically no significant differences were detected. In the case of  the NKG2D 
and PD1 proteins (Figure 31), we observed there is more variation in percentages of cells 







limitations as lack of reproducibility in those proteins with less expression. It has also been 
shown that a study of absence/presence is not the best approximation to infer changes in 
expression between our two conditions, since apparent changes in expression have been 
found invaluable by other validation techniques. This is why a quantitative proteomic study 
was carried out to more accurately detect those proteins differentially expressed. The tech-
nique chosen was metabolic labeling by heavy isotope-labeled amino acids (SILAC) (Ong 





Figure 30: Validation of CD28, CD80 and PD-L1 expression in WT, DGKα-/- and 
DGKζ-/- mouse CTL by flow cytometry.
Cells extracted from OT-I WT, OT-I DGKα-/- and OT-I DGKζ-/- mouse lymph no-
des were stimulated with OVA and differentiated in the presence of IL-2. (A) 
Expression profiles of CD28, CD80 and PD-L1. (B) Quantification of the MFI 






















































OT-I WT 1 OT-I WT 2 OT-I WT 3 Neg
OT-I DGKα-/- 1 OT-I DGKα-/- 2 OT-I DGKα-/- 3 Neg





Figure 31: Validation of NKG2D and PD1 expression in WT, DGKα-/- and DGKζ-
/- mouse CTL by flow cytometry.
As in the previous figure, mouse lymph node cells were extracted and then sti-
mulated and differentiated with OVA and IL-2. A staining was used to compare 
the expression of both markers on cells of OT-I WT, OT-I DGKα-/- and OT-I DGKζ-
/- mice. (A) Biparametric diagrams reflecting the percentages of simultaneous 
expression of NKG2D and PD1. (B) Quantification of mean percentages of 






















































For  the SILAC analysis, CTL were differentiated  from OT-I WT and DGKζ-/- mice. 
During differentiation, some cells from each mouse were cultured in normal medium and 
some in medium with SILAC-labeled amino acids (Figure 32A). At the end of the differ-
entiation, WT and DGKζ-/- cells were mixed 1:1 with and without labeling, alternately to 
generate two replicates with labels exchanged for the two treatments. Once the cells were 
mixed, they were subcellularly fractionated as in previous experiments, and analyzed by 
mass spectrometry.
We evaluated the degree of labeling with heavy amino acids of Jurkat T cells over 
time (Figure 32B). We could assess that after the days of labeling in IL-2 almost all the 
proteins have exchanged their arginines and lysines for their heavy equivalents (R+6 and 
K+6). From day 4 the percentage of labeled spectra exceeded 95%, which ensures that CTL 
labeling is appropriate, since these cells undergo a very marked expansion phase in the 
presence of IL-2.
3.2. Shotgun proteomics and GO analysis of SILAC proteomic results
From the fractions obtained by subcellular fractionation of the two replicates we per-









Replicate 1: WT (light) 
+ DGKζ-/- (heavy)WT CTL
DGKζ-/- CTL
Replicate 2: WT (heavy) 
+ DGKζ-/- (light)
Figure 32: Experimental design for SILAC analysis of CTL WT KOζ fraction-
ation.
(A) Scheme showing the experimental design for SILAC labeling. Cells extrac-
ted from mouse lymph nodes OT-I WT and OT-I DGKζ-/- were stimulated with 
OVA for 3 days and then cultured with IL-2 in the absence or presence of labe-
led amino acids (arginine and lysine). After this period, cells from alternative 
treatments were mixed in a 1:1 ratio and subcellular fractionation was perfor-
med as in previous analyzes. Cytosol, membrane and nuclear fractions were 
analyzed by LC-MS/MS. (B) Evolution of the labeling of Jurkat T cells when 
grown in medium with labeled arginine or lysine. The percentage of labeled 
spectra with at least one modification (K + 6 or R + 6) of all spectra exceeding 
a FDR <0.01 cutoff at the peptide level is plotted.
Fig. 28: Experimental design for SILAC analysis of CTL WT KOζ fractionation
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82%


























ilar in terms of number of proteins and reproducibility with respect to CTL fractionation 






















Cytosol Membrane Nucleus Total
Replicate 1
Replicate 2
Figure 33: Shotgun proteomic of quantitative SILAC fractionation.
(A) Number of proteins in total and in each fraction for both SILAC replica-
tes. (B) Overlap of the three fractions between the two conditions, in cytosol 
(top), membranes (middle) and nucleus (bottom) fractions. (C) Overlap wi-








































































Total Replicate 1 Cyt Replicate 1 Mem Replicate 1 Nuc
NUCLEAR 1452 49% 753 52% 1025 46% 1207 52%
CYTOPLASM 1489 50% 972 67% 1183 53% 1145 50%
PLASMA MEMBRANE 751 25% 313 22% 623 28% 532 23%
CELL SURFACE 136 5% 84 6% 113 5% 95 4%
PERINUCLEAR 264 9% 158 11% 207 9% 211 9%
GOLGI COMPLEX 167 6% 74 5% 142 6% 119 5%
ENDOPLASMIC RETICULUM 313 11% 86 6% 279 12% 228 10%
ENDOSOME 135 5% 48 3% 113 5% 100 4%
MITOCHONDRIAL 559 19% 182 13% 457 20% 461 20%
PEROXISOME 44 1% 19 1% 40 2% 33 1%
CYTOSKELETON 235 8% 137 10% 163 7% 190 8%
EXTRACELLULAR 977 33% 698 48% 879 39% 784 34%
2953 1442 2245 2301
Figure 34: Subcellular protein distribution of WT and DGKζ-/- CTL SILAC frac-
tionations according to GO terms.
Percentages of proteins classified according to GO terms, in replicate 1 (A and 
C) and replicate 2 (B and D). The results were almost identical between both 
replicates.
Total Replicate 2 Cyt Replicate 2 Mem Replicate 2 Nuc
NUCLEAR 1377 50% 769 53% 861 48% 1119 55%
CYTOPLASM 1425 52% 985 67% 988 55% 1056 52%
PLASMA MEMBRANE 646 24% 309 21% 497 28% 411 20%
CELL SURFACE 123 5% 79 5% 101 6% 86 4%
PERINUCLEAR 261 10% 156 11% 187 10% 197 10%
GOLGI COMPLEX 150 5% 77 5% 118 7% 97 5%
ENDOPLASMIC RETICULUM 259 9% 84 6% 219 12% 159 8%
ENDOSOME 119 4% 51 3% 86 5% 80 4%
MITOCHONDRIAL 502 18% 176 12% 324 18% 404 20%
PEROXISOME 35 1% 17 1% 29 2% 25 1%
CYTOSKELETON 227 8% 138 9% 139 8% 183 9%
EXTRACELLULAR 934 34% 689 47% 738 41% 738 36%






















































The bioinformatic quantitative analysis was carried out by Proteobotics S.L (Supple-
mental table 10). During this process from the data obtained through LC-MS/MS, searches 
were performed against databases using various search engines. The program algorithm 
was able to identify pairs of peaks for the same peptides with and without SILAC label-
ing, and to establish a quantitative relationship between them. Possible experimental al-
terations of the 1:1 ratio were avoided by normalizing the data obtained from the replicates 
for each fraction (Figure 35A). The quantitative results were represented according to their 
probability and the difference in expression between the WT and DGKζ-/- (Figure 35B, C). 
We observed that most of the proteins showed the same distribution in CTL from WT and 
the DGKζ-/- mice. We could however identify a signature of proteins with specific enrich-
ment in the plasma membrane fraction of the DGKζ-/- CTL compared to WT, and the same 
situation occurs in nucleus fraction. Within the proteins that present a differential regula-
tion, we focused our attention on the proteins that possessed the highest statistical confi-
dence, both in the case of the membrane fraction (Table 5) and in the case of the nucleus 
fraction (Table 6). 
Table 5: Proteins with confident up- or downregulation in membrane fraction. This table collects 
all the proteins that experienced up- and downregulation in the membranes fraction. The table 
shows the number of replicates in which they are detected, the number of peptides detected, the 
contrast performed and the type of differential regulation, the fold change in logarithmic scale, the 
FDR value, the protein ID and its description. Green and red colors indicate the DGKζ-/- upregulated 












2 7 DGKζ-/-/WT confident up 0.81 1.0e-006 0.00 P08882 Granzyme C
1 1 DGKζ-/-/WT confident up 6.87 1.0e-006 0.00 P11247 Myeloperoxidase
2 3 DGKζ-/-/WT confident up 0.66 1.0e-006 0.00 P18242 Cathepsin D
2 11 DGKζ-/-/WT confident up 0.86 1.0e-006 0.00 P04187 Granzyme B(G,H)
1 1 DGKζ-/-/WT confident up 1.12 4.1e-005 0.00 Q62418 Drebrin-like protein
2 5 DGKζ-/-/WT confident up 0.57 1.2e-004 0.01 P16110 Galectin-3
1 1 DGKζ-/-/WT confident up 1.75 2.0e-004 0.01 P11032 Granzyme A
1 1 DGKζ-/-/WT confident down -11.55 1.0e-006 0.00 Q8R3C6 Probable RNA-binding protein 
19
1 1 DGKζ-/-/WT confident down -10.98 1.0e-006 0.00 Q61941 NAD(P) transhydrogenase, 
mitochondrial
1 1 DGKζ-/-/WT confident down -4.07 1.0e-006 0.00 Q6PB44 Tyrosine-protein phosphatase 
non-receptor type 23
1 1 DGKζ-/-/WT confident down -5.99 1.0e-006 0.00 O35929 GTP-binding protein REM 1
2 2 DGKζ-/-/WT confident down -0.86 1.2e-004 0.01 Q9CYG7 Mitochondrial import recep-
tor subunit TOM34
1 1 DGKζ-/-/WT confident down -1.72 2.0e-004 0.01 P21995 Embigin
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Figure 35: Quantitative SILAC analysis of subcellular fractions.
(A) The results obtained in membrane (left), nucleus (center) and cytosol (ri-
ght) fractions by analyzing the LC-MS/MS data were normalized to fit the pro-
bability model for a 1:1 ratio between the two treatments (WT and DGKζ-/-) in 
every replicate. This normalization was applied to all fractions of the two in-
verse labeling replicates. (B) Volcano plots showing the differential expression 
between the WT and DGKζ-/- proteins for each of the fractions. The data were 
obtained from the two replicates of each fraction. The magnitude of the chan-
ge in the expression is represented, as well as the probability that it is real. (C) 
Categorization of the total proteins detected by the analysis according to the 











DGKζ-/-/ WT  
Cytosol
Confident up 16 Confident up 14 Confident up 2
Likely up 6 Likely up 0 Likely up 26
Putative up 65 Putative up 27 Putative up 70
None 1689 None 1482 None 1273
Putative down 57 Putative down 40 Putative down 109
Likely down 5 Likely down 5 Likely down 36
Confident down 15 Confident down 26 Confident down 6






Table 6: Proteins with confident up- or downregulation in nuclear fraction. As in the previous 
table, here we collect all the proteins that experienced up- and downregulation in the nuclear 
fraction. The table shows the number of replicates in which they are detected, the number of pep-
tides detected, the contrast performed and the type of differential regulation, the fold change in 
logarithmic scale, the FDR value, the protein ID and its description. Green and red colors indicate 












1 1 DGKζ-/-/WT confident up 7.28 1.0e-006 0.00 J3QPY6 Protein Gm21957
1 1 DGKζ-/-/WT confident up 2.50 1.0e-006 0.00 P25976 Nucleolar transcription factor 
1
1 1 DGKζ-/-/WT confident up 4.44 1.0e-006 0.00 P47968 Ribose-5-phosphate isomerase
2 5 DGKζ-/-/WT confident up 1.40 1.0e-006 0.00 Q00PI9 Heterogeneous nuclear RNP-
U-like protein 2
1 1 DGKζ-/-/WT confident up 1.42 3.4e-004 0.01 Q61035 Histidine--tRNA ligase, cyto-
plasmic
1 1 DGKζ-/-/WT confident up 1.42 1.0e-004 0.00 Q8BQ30 Phostensin
1 2 DGKζ-/-/WT confident up 1.28 1.0e-006 0.00 Q8CIE6 Coatomer subunit alpha
1 4 DGKζ-/-/WT confident up 2.57 1.0e-006 0.00 Q99L45 Eukaryotic translation initia-
tion factor 2 subunit 2
1 1 DGKζ-/-/WT confident up 5.88 1.0e-006 0.00 Q9QWR8 Alpha-N-acetylgalactosamin-
idase
1 1 DGKζ-/-/WT confident down -3.56 1.0e-006 0.00 D3Z6Q9 Bridging integrator 2
1 1 DGKζ-/-/WT confident down -4.39 1.0e-006 0.00 O08664 B-cell CLL/lymphoma 7 protein 
family member C
1 1 DGKζ-/-/WT confident down -7.05 1.0e-006 0.00 O35929 GTP-binding protein REM 1
2 9 DGKζ-/-/WT confident down -0.95 1.0e-006 0.00 P04187 Granzyme B(G,H)
2 4 DGKζ-/-/WT confident down -1.67 1.0e-006 0.00 P11032 Granzyme A
2 3 DGKζ-/-/WT confident down -0.66 3.0e-004 0.01 P16045 Galectin-1
1 2 DGKζ-/-/WT confident down -3.72 1.0e-006 0.00 P18155 Bifunctional methylenetetra-
hydrofolate dehydrogenase/
cyclohydrolase, mitochondrial
2 5 DGKζ-/-/WT confident down -0.78 1.4e-004 0.01 P42225 Signal transducer and activa-
tor of transcription 1
2 1 DGKζ-/-/WT confident down -1.43 1.0e-006 0.00 P53994 Ras-related protein Rab-2A
2 2 DGKζ-/-/WT confident down -2.30 1.0e-006 0.00 P56395 Cytochrome b5
1 1 DGKζ-/-/WT confident down -5.50 1.0e-006 0.00 P62748 Hippocalcin-like protein 1
2 2 DGKζ-/-/WT confident down -1.28 1.0e-006 0.00 Q62351 Transferrin receptor protein 1
1 1 DGKζ-/-/WT confident down -1.78 2.1e-005 0.00 Q8BJS4 SUN domain-containing 
protein 2
1 1 DGKζ-/-/WT confident down -2.72 1.0e-006 0.00 Q9CZX9 ER membrane protein com-
plex subunit 4
1 1 DGKζ-/-/WT confident down -5.09 1.0e-006 0.00 Q9D4H7 LON peptidase N-terminal 
domain and RING finger 
protein 3




 To help understand the role of these proteins, we performed a functional study using 
DAvID (Huang et al., 2009b) and graphically represented it by EnrichmentMap plugging 
of Cytoscape (Merico et al., 2010) (Figure 36). There was a significant presence of lytic pro-
teins related to cytotoxicity such as granzymes A, B and C and myeloperoxidase, as well as 
components of lysosomes such as cathepsins, drebrin-like protein, and regulators of apop-




these proteins did not present changes in the differential expression (Table 7). Only some 
of them presented changes, and they were not always included in the confident category of 
the analysis. For example, the transferrin receptor (CD71) was increased in the membrane 





















Figure 36: Functional analysis of SILAC subcellular fractions.
We performed a DAVID functional annotation analysis of confident regu-
lated proteins for biological process from GO, pathways from Biocarta and 
keywords from Uniprot, with a p-value cutoff of 0.05, and represented it by 
Enrichment Map plug-in of Cytoscape. Bigger nodes indicate greater number 
of proteins assigned. The inner ring of each node refers to membrane fraction 
proteins, while the outer ring refers to the nucleus fraction. The more red 
color the nodes have, the more significant the enrichment for that category 
is. Thicker edges mean higher protein overlap between two categories. The 
edges are green or purple depending on if they bind proteins from the mem-
brane or nucleus fractions, respectively. Results show an overrepresentation 
of proteins related with cytotoxicity.
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Table 7: CD proteins detected in SILAC analysis. The CD proteins detected in the membrane, cytosol and nu-
cleus fractions are classified according to the confidence observed in their differential regulation (from major 
to minor, confident, likely, and putative). The proteins with the greatest expression in DGKζ-/- CTL versus WT 
are represented in green, and those whose expression is lower in red. CD proteins with no evidence of diffe-
rential regulation are shown in gray.
Membrane Cytosol Nucleus





CD71 Transferrin receptor protein 1
Li
ke
ly CD71 Transferrin receptor protein 1 CD8b
T-cell surface glycoprotein CD8 
β chain





CD3e T-cell surface glycoprotein CD3 ε chain CD11a Integrin α-L CD3e
T-cell surface glycoprotein CD3 
ε chain
CD298 Sodium/potassium-transporting ATPase subunit β-3 CD18 Integrin β-2
CD43 Leukosialin CD98 4F2 cell-surface antigen heavy chain
CD45 Receptor-type tyrosine-protein phosphatase C CD223
Lymphocyte activation gene 3 
protein




CD3d T-cell surface glycoprotein CD3 δ chain CD3d
T-cell surface glycoprotein CD3 
δ chain CD25 IL-2 receptor subunit α
CD18 Integrin β-2 CD25 IL-2 receptor subunit α CD45 Receptor-type tyrosine-protein phosphatase C
CD25 IL-2 receptor subunit alpha CD43 Leukosialin CD90 Thy-1 membrane glycoprotein
CD44 CD44 antigen CD44 CD44 antigen CD98 4F2 cell-surface antigen heavy chain





CD90 Thy-1 membrane glycoprotein CD47 Leukocyte surface antigen CD47 CD223 Lymphocyte activation gene 3 protein
CD98 4F2 cell-surface antigen heavy chain CD48 CD48 antigen CD229
T-lymphocyte surface antigen 
Ly-9
CD100 Semaphorin-4D CD51 Integrin α-V CD247 T-cell surface glycoprotein CD3 ζ chain
CD222 Cation-independent man-nose-6-phosphate receptor CD84 SLAM family member 5
CD223 Lymphocyte activation gene 3 protein CD90 Thy-1 membrane glycoprotein
CD100 Semaphorin-4D
CD298 Sodium/potassium-transporting ATPase subunit β-3
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4. CTL cytolitic granules analysis
Our quantitative proteomics studies using SILAC have allowed us to find changes in 
protein expression between CTL obtained  from DGKζ-/- and WT mice, including protein 
components of cytotoxic granules. These changes have been increased for DGKζ-/- CTL in 
the case of the fraction of membrane, which can point to differences in number of secretory 
lysosomes. To further explore this aspect, we carried out experiments with a probe that 
allows  the monitoring of  the  lytic granules of cytotoxic cells. This probe, LTG,  is a fluo-
rescent molecule that is internalized in cellular compartments with acid pH as lysosomes 
(Chazotte, 2011). LTG has been used in previous studies to monitor cytotoxic granules of 
activated CD8+ cells (Shen et al., 2006). Thus, we can analyze the dynamics of these com-
partments and verify the existence of differences between our two conditions that may ex-
plain the data obtained by proteomics.
4.1. Titration of LTG
First, we performed an LTG titration to check different staining parameters. We used 
differentiated CTL using  our  standard protocol,  and mixed  cells  from WT, DGKα-/- and 
DGKζ-/- mice to take into account the variability that might exist in the production of cyto-
lytic granules under different conditions. We checked different concentrations of the probe, 
as well as the duration of the staining and if the staining medium was changed to PBS or it 
remained. The results showed that increasing concentration, time or keeping RPMI culture 
medium for staining yielded greater staining of cells (Figure 37A and Figure 37B). Howev-
er, the largest differences were produced by the staining incubation medium. In the case 
we kept RPMI staining medium, the staining of the population was uniform and intense, 




rescence microscopy (Figure 37E and Figure 37F). We can see how the saturation effect 
occurred mainly by incubation in RPMI medium, where there was staining not only of cy-
tolytic granules but also of cytosol and other compartments such as Golgi. This saturation 
effect is not so marked when comparing high and low LTG concentration. We concluded 





Figure 37: Lysotracker green titration in CTL.
(A) CTL stained with LTG were analyzed by flow cytometry to measure the 
fluorescence intensity of this dye. Differentiated CTL from mixed WT, DGKα-
/- and DGKζ-/- mice were used for titration. Different staining conditions, such 
as time in the presence of dye (2 or 30min), and if the RPMI staining medium 
was changed to PBS or was kept, were evaluated. (B) Compilation of the MFI 
of the different titration experiments. (C and D) Confocal microscopy analysis 
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4.2. LTG labeling of CD4+ versus CD8+ cells
 After optimizing the conditions for LTG staining, we studied the behavior of LTG 
over time for CD4+ and CD8+ cells obtained from mice deficient in DGKα or DGKζ, and 
stimulated with concanavalin A and IL-2. Thus, it is possible to check the formation of 
granules in CD8+ cells from activation to differentiation, with special interest in the effect 
of DGKα-/- and DGKζ-/- cells, as well as the behavior in CD4+, where generation of lysosom-
al granules has been reported (Shen et al., 2006). The results showed that at day 0 naïve 
cells remained with narrow LTG peaks, and that after three days of stimulation they had 
shifted, increasing the fluorescence intensity (Figure 38). However there were hardly any 
Figure 38: Evolution of LTG over time in CD4+ and CD8+ cells.
Splenocytes obtained from WT, DGKα-/- and DGKζ-/- mice were stimulated in 
vitro with concanavalin A for 48h, and then differentiated with IL-2. The cells 
were stained with anti-CD4 and CD8 antibodies, and then the fluorescence 
intensity of LTG was measured on cells stained in RPMI medium at 50nM and 
then transferred to PBS. When analyzing the results, we gated CD4 or CD8 
populations of cells according to each case. For days 5 and 7 the acquisition 

















and CD8+ cells  showed greater  intensity of LTG  than CD4+ cells, differences  that were 
already reduced to day 7. As in the titration we observed that WT cells had higher fluores-
cence intensity than in the case of DGKα-/- and DGKζ-/-.
4.3. LTG labeling during CD8+ stimulation
In the previous experiment we analyzed the evolution of LTG labeling of CD4+ and 
CD8+ cells over time. Focusing on CD8+ cells, we observed that large changes in LTG ex-
pression occurred. For this reason, we analyzed in greater detail the changes in staining 
during  secretory  lysosomes development. From WT, DGKα-/-  and DGKζ-/- cells obtained 
















Figure 39: Evolution of LTG over time in CD8+ cells.
Cells extracted from lymph nodes of OT-I mice WT, DGKα-/- and DGKζ-/- were 
stimulated with the OVA peptide for 3 days, and then expanded with IL-2. 
LTG staining was performed every 24 hours to evaluate the development of 
cytolytic granules, according to the protocol used in previous experiments. A 
staining with anti-CD8 antibody was carried out to be able to gate the CD8+ 
population during first three days. The graph shows quantification of LTG 
mean fluorescence intensity of the three conditions (WT, DGKα-/- and DGKζ-/-) 





1. Optimization of plasma membrane protein enrichment meth-
ods
Characterization of the human proteome and the function of proteins was the next 
logical step after the determination of the human genome sequence (Kaiser, 2002). Cur-
rently, approximately 20,000 revised proteins are registered without considering isoforms 
(The UniProt Consortium, 2017). The enormous complexity of the proteome has made it 
necessary to subdivide it before its study in the case of strategies based on mass spectrom-
etry. By following a targeted method for each subproteome it is possible to detect a larger 
number of proteins globally. In the case of membrane proteins using bioinformatic ap-
proaches it has been estimated that there are 4800 proteins with transmembrane domains, 
of which about 3700 belong to the cell surface; and 304 of the CD group are surface pro-
teins, which  represents an 85% (da Cunha et al., 2009). The combined study of  several 
bioinformatics applications to predict transmembrane proteins retrieves about 5539 mem-
brane proteins (Fagerberg et al., 2010). In Uniprot there are about 2300 proteins annotat-
ed as surface proteins (Bock et al., 2012), considering the total human proteome and not 
a particular cell lineage. With these limits in mind, we tried to determine as many of these 
proteins as possible in our study.
1.1. Biotinylation
To achieve our goal we must focus on studies on the CTL proteome (Hukelmann et 
al., 2016). In this work, a global analysis of the CTL proteome is performed with high res-
olution mass spectrometry. The number of protein groups obtained reaches 6800, from 
which there is a great difference in expression, since for example only 12 proteins represent 
25% of  the  total proteome mass, with several orders of magnitude compared to  the  less 
frequent ones. In our study we obtained about 4359 by a single acquisition by mass spec-
trometry. By means of our biotinylation enrichment approach we were able to detect 2126 
proteins,  of which 668 were  classified as plasma membrane proteins, which  constitutes 
31%. This represents a modest increase in plasma membrane proteins, as the total Jurkat 
lysate yielded 922 proteins, about 21%. In other words, despite the fact that contamination 
with other subcellular fractions is reduced, the number of plasma membrane proteins is 





with traditional proteomics techniques using two-dimensional gels and spot extraction, al-
though the biotinylation enrichment process is similar (Peirce et al., 2004). In this work, 
the replacement of the gel isoelectric focusing by a solution allows to improve the results 
up to 74 membrane proteins out of 127 detected (58.3%). Among the shotgun proteomics 









is high, the proportion with respect to the total is lower than the studies cited. In the case of 
mouse T-lymphocytes this percentage remains similar in both splenocytes and CTL.
1.1.1. Alternative biotinylation approaches
In our study we implemented some strategies to improve the results obtained by 
biotinylation. These included the application of intensive high salt concentration washes 
to prevent the non-specific binding of proteins to complexes of biotinylated proteins and 
beads with neutravidine. While the application of additional washes may involve protein 
loss, it may improve plasma membrane protein percentages. However, the results obtained 
did not seem to differ. Similar results have been described with high salt washes, as well as 
with other strategies such as pleclearing, sucrose washing or Na2CO3 (Weekes et al., 2010), 
so we discarded this strategy. 
Another optimization attempt was carried out by choosing a different biotin reagent 
including an internal disulfide bridge. This modification increases its molecular mass and 
favors the solubility of the molecule by reducing hydrophobicity, factors that hinder its 
ability to cross the plasma membrane and its internalization in the cytosol. Analysis of this 
undesired internalization of biotin by confocal microscopy showed no differences between 
two biotin molecules, although other studies have detected a reduction in permeability in 
the case of S-S-biotin with improved performance (Peirce et al., 2004). The use of this bio-
tin does not ensure obtaining a great enrichment (Weekes et al., 2010). Although western 
blot analysis does seem to isolate a greater amount of a plasma membrane marker, the 
Discussion
113
transferrin receptor, the percentages of plasma membrane proteins are maintained in the 
following experiments in numbers similar to the original biotin. The use of S-S-biotin does 
not guarantee a good percentage of plasma membrane proteins. In addition, although the 
disulfide bridge could be used to recover proteins by a reduction treatment as indicated in 
the manufacturer’s instructions, the highest yield is achieved by boiling the samples as in 
the original biotin. An advantage of the use of S-S-biotin, however, is that the loss of biotin 
moiety by the reduction of the disulfide bridge would avoid possible biotin interference in 
mass spectrometry detection, although part of the tag would still be present in the peptide 
(Markoutsa et al., 2014).
1.2. Fractionation
Another strategy developed in our study was to perform subcellular fractionation us-
ing a commercial kit from Calbiochem (Hwang & Han, 2013). With this tool it was possible 
to isolate cytosol, membrane and nuclear fractions. By means of western blot we verified 
how effectively each fraction was enriched with the proteins corresponding to each fraction. 
These results coincided with previous studies documenting a limited carry-over (Abdolz-
ade-Bavil et al., 2004; Hwang & Han, 2013). However, the proteomic analysis showed a 
high level of overlap between the three fractions. This is possible, since although a protein 
belonging to a fraction is mostly retained in it, it can remains in other fractions in levels that 
can be detected by mass spectrometry. This phenomenon is observed when analyzing the 
presence of CD proteins. Although these proteins are detected in all three fractions, they 
are all contained in the membrane fraction, except in one case in RP-HPLC fractionation 
replicate. Likewise, limitations of the kit have been described when analyzing specific frac-
tions, such as the case of the nuclear fraction (Murray et al., 2009).
By subcellular fractionation we obtained about 5594 proteins in Jurkat cells in SDS-
PAGE replicate and about 5900 in RP-HPLC replicate. These data are close to but below 
6800 proteins (Hukelmann et al., 2016), which may be partly due to the fact that the cy-
toskeleton fraction that allows the kit to be separated has not been analyzed. Within the 
membrane fraction the numbers obtained were 4684 and 4801 proteins in the two repli-
cates respectively, of which 1269 and 1255 were included in plasma membrane proteins, 
representing 27% and 26%. The enrichment is slightly lower, possibly because this fraction 
is actually enriched not only in plasma membrane proteins, but also in other endomem-
brane proteins such as endoplasmic reticulum and Golgi apparatus. However, it is true that 
globally more plasma membrane proteins were detected than in the case of biotinylation, 






CD proteins were obtained than in the other biotinylation experiments. Both methodolo-
gies therefore have their advantages and can help us to obtain information about the plas-
ma membrane proteome of our cells of interest.
As mentioned above, the proteins of the fractions obtained through the subcellular 
fractionation kit were separated by 1D-SDS-PAGE or RP-HPLC in basic medium. In this 
way, it was possible to verify which strategy could recover a greater number of plasma 
membrane proteins, which contain hydrophobic regions that can make solubilization dif-
ficult  (Vit & Petrak, 2017). The number of plasma membrane proteins obtained  in each 
method was similar, although higher in the case of chromatographic separation. However, 
when looking at the number of CD proteins, more were detected in gel separation. In view 
of these similar numbers, we opted for greater detection of these cell surface proteins, and 
therefore the following fractionations were carried out with gel separation.
1.3. Future strategies
In all the approaches we have carried out, problems of contamination with non mem-
brane proteins have arisen. One of the possible causes would be the presence of cellular 
debris from dead cells or cell fragments that could have been marked with biotin, in spite 
of the abundant washing before and after the labeling (Weekes et al., 2010). Another cause 
could be certain degree of permeability of biotin, although it predominantly labels plasma 
membrane proteins (Peirce et al., 2004). In general, these causes will always be present 
and other aspects of the enrichment protocol should be improved. During this discussion, 
several studies have been cited that propose different strategies, which in some cases are 
contradictory to each other; some defend amino-oxy-biotin against sulfo-NHS-SS-biotin 
(Weekes et al., 2010), while others argue just the opposite (Hörmann et al., 2016). Perhaps 
an attractive solution would be an approach combining different strategies, such as bioti-
nylation tagging and glycosylated protein isolation (Hofmann et al., 2010), although the 
difficulty of replicating this methodology by other laboratories has been recognized (Vit & 
Petrak, 2017). In short, there is probably no optimal methodology to replace the others, but 
each laboratory must carry out different complementary strategies whenever it reports an 
adequate number of plasma membrane proteins.
Another problem is the identification of the subcellular location of proteins by con-
sulting the Gene Ontology database. In many cases the proteins are either not annotated 




2010). In our study we observed that when analyzing the overlap between GO terms, not all 
cell surface proteins were contained in plasma membrane proteins. Furthermore, while the 
overlap between cytosol and plasma membrane proteins may be plausible, it is more un-
likely in the case of cytosol and cell surface proteins, as these are oriented towards the outer 
cell membrane. The ontological annotation of the databases should probably be improved. 
These inconsistencies may be due to the fact that much of the annotations have been in-
ferred by electronic evidence and may be incorrect, and even though there is information 
in the scientific literature to complete the annotations, it is possible that they have not yet 
been completed, or have not pass through a curation process (Khatri & Draghici, 2005). An 
option for possible future studies could be the use of different softwares with access to other 









The PMA molecule is a phorbol ester that acts as a potent analog of DAG, and that has 
been used for the study of signaling (Kazanietz & Lorenzo, 2003). Its effectors include pro-
teins with DAG binding domains, mainly PKC, as well as chimerins, Munc13, RasGRP, PKD 
and some DGK (Brose & Rosenmund, 2002). The DGK are responsible for the metabolism 
of the DAG (Mérida et al., 2008), so the addition of PMA can simulate a lack of activity, 
since the PMA is not consumed by the DGK.
To evaluate the importance of DGK in the expression of CTL membrane proteins, we 
carried out proteomics experiments in the absence and presence of PMA. One of the effects 
of PMA that particularly affects  the expression of cell  surface proteins  is  shedding. This 
phenomenon consists of the release of extracellular domains of membrane proteins due to 
the action of proteolytic enzymes known as sheddases. On the one hand, the expression of 
the target proteins is negatively regulated, since only the membrane and intracytosolic do-
mains would remain unaltered. In addition, the soluble factors released may be involved in 





other studies, we conducted a proteomics approach to detect proteins whose expression 
might be affected by shedding (Ahram et al., 2005; Shirakabe et al., 2014).
In the analysis of cell surface proteins we focused on proteins classified as CD. The 
results showed that most of these surface proteins were common to both replicates, indi-
cating acceptable reproducibility in experiments. In most cases, the same proteins were 
detected in both PMA and non PMA treatments. There is a case in both replicates where 
a protein was detected only in the PMA free treatment, which would indicate that it could 
have undergone a shedding process. This was CD120b, or tumor necrosis factor II receptor 
(TNFR-II). This molecule is described as a protein regulated by the action of shedding, 
which can be triggered by the addition of PMA (Porteu & Nathan, 1990). The role of TNF re-
ceptors has been associated with the activation of apoptosis pathways (Tseng et al., 2018), 
although in the case of TNFR-II a additional role as a co-stimulatory molecule during TCR 
activation has been demonstrated (Aspalter et al., 2003), so their elimination by shedding 
would act as a brake on the activation of these cells.
In other cases, loss of expression of membrane proteins was detected in only one of 
the replicates. This may be due to a very limited level of expression that may cause a pro-
tein not to be detected in all replicates. Among these cases were proteins such as CD49b or 
integrin α2, which acts as a subunit of the VLA-2 receptor (Hemler et al., 1985). Shedding 
processes have been described for integrins, also for α2 but in other cell types (Friedl et al., 
1997), although in our proteomic analysis many other integrins were detected within CD49, 
so it is likely that their absence was due to a lack of adequate detection. A similar situation 
would occur in the case of the tyrosine kinase receptor CD167a, known as DDR1 (Epithelial 
discoidin domain-containing receptor 1), which also experiences shedding when binding 
to its collagen binding ligand (vogel, 2002), and has been described as a T-cell coactivator 
(Dang et al., 2009). Also CD115, or CSF1R (macrophage colony-stimulating receptor fac-
tor), which undergoes shedding dependent on TACE/ADAM (Wilhelmsen & van der Geer, 
2004). There is less information on evidence of shedding with CD217, the IL-17 receptor. 
To confirm the existence of shedding with all these molecules, a direct validation test must 
be used to measure protein expression under both conditions.
In the opposite situation would be those cell surface proteins detected only in PMA 
treatment. These proteins would not be present or with limited expression in the absence 
of treatment, while the addition of PMA would favor their expression or migration to the 
membrane. Again, this fact occurs in only one of the two replicates, so it could be due to 
insufficient  sensitivity of  the equipment. Within  these proteins are  the CTLA-4  (CD152) 
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and PD1 (CD279) receptors, involved in the negative regulation of T cell signaling after 
activation, which would be consistent with the expression pattern detected (Agata et al., 
1996; Linsley et al., 1992). CD73 or 5’-nucleotidase, which converts AMP into adenosine, 
would also be expressed. This molecule has a role in the co-stimulation of T lymphocytes 
(Resta et al., 1998), and like the two previous proteins is considered a checkpoint for its 
ability to inactivate the T lymphocyte response (Chatterjee et al., 2014). Activation could 
lead to increased expression. In the case of CD253 or TRAIL (TNF-related apoptosis-in-
ducing ligand), involved in apoptosis (Wiley et al., 1995), T-cell activation promotes its own 
expression (Mariani & Krammer, 1998). The addition of PMA would prevent TRAIL-medi-
ated apoptosis mechanisms (Guo & xu, 2001). Less clear is the case of CD254 or TRANCE 
(TNF-related activation-induced cytokine receptor), a molecule related to apoptosis and 
calcium regulation in bone (Akiyama et al., 2012). Although its expression in T cells is in-
duced after activation  (Josien et al.,  1999),  the addition of PMA would not be sufficient 
to trigger its increased expression (Wang et al., 2002). Something similar would happen 
with CD221 or IGF1R (insulin-like growth factor-1 receptor), a tyrosine kinase receptor that 
binds to IGF (insulin-like growth factor)-1 and 2 (Chitnis et al., 2008), where a decrease in 
expression by the addition of PMA has been described (Schillaci et al., 1998). This receptor 
would also have a negative effect on PMA-induced shedding (Li et al., 2009).
In addition to the possible problems mentioned above, variations not detected by this 
proteomic presence/absence technique may occur. When there is detection in both PMA 
and non PMA treatments, the protein in question would have detectable levels in both cas-
es. However, this would not necessarily mean that the protein is expressed in exactly the 






on cell signaling (Krishna & Zhong, 2013). For this purpose we have used the biotinylation 
and subcellular fractionation techniques carried out on differentiated CTL cells from DGKζ-
/- mice versus WT mice. The use of two different enrichment techniques has influenced the 
increase in variability, compared to the PMA study where two replicates of the same bioti-
nylation technique were analyzed. Another challenge was the reduced expression of CD 
proteins despite the pre-enrichment process, which can hinder their detection during pro-




comparison with the previous data provides us an overview of all the CD proteins detected 
in the different experiments, which allows us to establish a snapshot of the cell surface ex-
pression in CTL. 102 proteins have been detected considering all experiments, and in 95 of 
them at least one replicate has been detected in the two conditions studied, either minus/
plus PMA or WT versus DGKζ-/- cells, depending on the case.
Although proteomic data are validated by statistical filters (Nesvizhskii et al., 2007), 
techniques such as detection through a specific antibody by western blot or flow cytom-
etry, or techniques such as targeted proteomics (Picotti & Aebersold, 2012) can be used 
to check the effective change in expression between two conditions. In our case, we used 
immunocytometry techniques, where specific antibodies to these proteins can be used to 
measure their expression on the surface. We measured the expression of CD28, a molecule 
expressed in both conditions, and CD80, CD314 and CD274, which were expressed only 
in WT in some of the proteomics experiments. We extended the study to CD279 (PD1), 
the CD274 (PD-L1) receptor, already commented previously in the introduction. We also 
measured the expression of CD314 or NKG2D, a receptor activator of NK cells also present 
in CTL cells where it acts as a co-stimulatory molecule, and reinforces its cytotoxic action 
(Upshaw & Leibson, 2006). No differences were detected in any of these proteins. Howev-
er, this does not mean that these molecules do not have an impact on cell phenotype DGKζ-
/-. It has been demonstrated that in the case of both NKG2D and PD1 there is an increase of 
around 1% in CD8+ CD44hi CD122hi cells (Andrada et al., 2017).
3. Quantitative study
After the results of the presence/absence proteomic studies, we changed our strategy 
towards a quantitative approach using SILAC metabolic labeling. By means of this tech-
nique we compared the expression of proteins that are present in different amount between 
two conditions. During its implementation, several experimental errors can occur. One of 
them is the arginine-to-proline conversion, which in our case we have solved by adding a 
higher concentration of proline to the culture medium. Another possible problem would 
be incomplete labeling with heavy amino acids, but their incorporation to cells was close 
to 100%. Finally, the possible error in the proportion of the two samples in a 1:1 ratio is 
compensated by a statistical correction, with a very good approximation in the case of the 
membrane fraction and the nuclear fraction. The experimental design with two replicates 





changes were in proteins that are components of the lytic granules of CTL such as gran-
zymes A, B and C and cathepsin D. There would also be an increase in the expression of 
galectin-3, a protein that increases its expression in activated T cells (Joo et al., 2001), 
which would correspond to a state of increased proliferation and activation due to the ab-
sence of DGKζ. This protein has a role in the initiation of apoptosis, so it may be used by 
tumors for immune evasion (Fukumori et al., 2003). On the other hand, tyrosine-protein 
phosphatase non-receptor type 23 (PTPN23) protein is related to the traffic of ubiquitinat-
ed proteins to multivesicular bodies (Doyotte et al., 2008). There are no CD proteins with 
a variation within the highest confidence range, but a single protein in the likely range: the 
transferrin receptor. As commented earlier in the results section, the lower expression of 
this receptor can be explained by an internalization of the receptor due to the absence of 
DGKζ (Rincon et al., 2007).
Within nuclear proteins we can highlight STAT1, a transcription factor activated by 
several cytokines, among which is IFNγ (Leonard & O’Shea, 1998), with a higher produc-
tion in the case of mice DGKζ-/- (Wesley et al., 2018). The ubiquitination of STAT1 by a sus-
tained ERK activation like occurs in DGKζ-/- mice may explain why they have lower STAT1 
expression levels (Y. Zhang et al., 2018). Another transcription factor detected in one rep-
licate, NFAT5, is activated in response to osmotic stress and helps to regulate lymphocyte 
activation (Go et al., 2004).
4. Analysis of CTL lytic granules
Once we have seen that there is more expression of granzymes and granule proteins, 





process. To check this we used a probe capable of labeling the acid compartments or lyso-
somes, which in the case of CTL correspond to the lytic granules (Blott & Griffiths, 2002). 
Titration gave us a guarantee  that contamination of  the cytosol was avoided, as verified 
by microscopy. On  the other hand, flow  cytometry measurement was  able  to detect  the 








amount of granzymes, both at the mRNA level (Andrada et al., 2017) and at the protein 
level (Wesley et al., 2018). In this way, the differences in granzyme expression detected by 
proteomics have been validated, leading the way for the rest of the proteins with differential 
expression. Our methodology based on quantitative proteomics has shown to be able to 
detect these candidate proteins. The data obtained helps to understand how DGKζ deficient 
CTL are more effective removing tumors (Riese et al., 2011), an enzyme that represents a 





1.  The techniques of biotinilation and subcellular fractionation allowed an enrich-
ment from 20% to 30% of membrane proteins  in both Jurkat cells and mouse 
lymphocytes. In the case of fractionation, more plasma membrane proteins were 
obtained than by biotinylation, although this technique recovered more CD pro-
teins in mouse CTL.
2.  In PMA experiments, 5 CD proteins were expressed only in the absence of PMA 
and 6 only in the presence of PMA, of a total amount of 83 CD proteins detected 
by CTL biotinylation, at least in some replicate. Among those CD proteins ex-
pressed only in the absence of PMA, proteins with possible shedding regulation 
such as CD49b, CD115, CD120b, CD167a and CD217 were included.
3.  When comparing WT and DGKζ-/- CTL, 26 CD proteins  showed differences  in 
expression of a total amount of 77 CD proteins detected, in at least one of the rep-
licates. However, when some of them were analysed by flow cytometry, no such 
changes in expression were detected.








1.  Las técnicas de biotinilacion y fraccionamiento subcelular permiten un enrique-
cimiento de un 20% a un 30% de proteínas de membrana, tanto en células Jurkat 
como en linfocitos de ratón. En el caso del fraccionamiento se obtienen más pro-
teínas de membrana plasmática que mediante biotinilación, aunque esta técnica 
recupera más proteínas CD en CTL de ratón.
2.  En los experimentos con PMA, 5 proteínas CD se expresaron solo en ausencia de 
PMA y 6 solo en presencia de PMA de un total de 83 proteínas CD detectadas por 
biotinilación de CTL, al menos en alguna réplica. Dentro de las proteínas CD que 
solo se expresan en ausencia de PMA se hallan proteínas con posible regulación 
por shedding como CD49b, CD115, CD120b, CD167a y CD217.
3.  Al comparar CTL WT y DGKζ-/-, 26 proteínas CD mostraron diferencias en la ex-
presión de un total de 77 proteínas CD detectadas, en al menos una de las ré-
plicas. Sin embargo, al analizar su expresión mediante citometría de flujo no se 
detectaron cambios.
4.  El análisis cuantitativo mostró un incremento de la expresión de proteínas de 
granzima, catepsina y galectina en CTL deficientes en DGKζ, responsables de los 
procesos de citotoxicidad. Estos cambios no se debieron a diferencias relaciona-
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1. Appendix I: Supplemental tables
Supplemental table 1
Proteins identified in a shotgun analysis of Jurkat T cells treated with PMA, enriched 


















riched in membrane proteins after biotinylation and neutravidin pull down. See attached 
Excel file “SuppTable6” on CD.
Supplemental table 7
Proteins  identified  in a  shotgun analysis of DGKζ-/- mouse CTL enriched in mem-
brane proteins after neutravidin pull down. See attached Excel file “SuppTable7” on CD.
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